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GENERAL INTRODUCTION 
Bovine respiratory disease is an acute infectious disease of 
young cattle characterized ·by fever, nasal discharge, coughing,, and 
fibrinous pneumonia followed in some cases by de.ath (2, 57, 58) • The 
economic loss to the cattle industry in the United states from the 
disease was reported to be millions of dollars annually, excluding 
best of treatment or preventive measures (1) • Studies on etiology of 
the disease have indicated that the disease may be the result of a 
complex interaction or cumulative effect of viruses, bacteria, 
mycoplasma, chlamydiae and environmental factor9 (33, 101). 
Pasteurella multocida (P. multocida) is a major etiological agent - ' ' 
in .bovine respiratory disease (25, 32), with capsular type A strairs 
11Dst frequently isolated in North Amer_ica. Sane encapsulated strains 
. ' - - ' ' . . ( 
of ~ multocida are known to be highly pathogenic, in experimental 
animals and the presence of the mucoid capsule is important f 0r 
virulence (25, 34). The capsule of type A strains is primadly 
composed of hyaluronic acid (26, 28) which serves as·a frainework for 
the attachment of polysaccharides, proteins a.nd lipids (25). 
'!be importance of Pasteurellae in bovine respiratory disease has 
led to the development and use of various bacterin products, .either 
commercial or experimental, for immunization. The efficacy and s~fety 
9f most of these products still remains in question (9,r_ 42, 49, 64, 
71). There is evidence that the Use of bacterins which are curFently 
available may in fact be detrimental to the health qf the animal (9, 
2 
42, 71) • 
Recently,· efforts have been made to find effective immunizing 
agents to prevent infection by ~ multocida including viable vacc.inal 
strains such as attenuated avirulent strains (14, 67, Hl2), 
streptomycin-dependent mutants (30, 31), and a chemically altered 
strain (63, 100). Also, lysates of turkey-grown bacteria (18, 87, 88, 
89) as well as isolated cellular fractions of the organism such as 
endotoxin (54, 84, 85, 86), free endotoxin (43, 53, 84), ribosomal 
proteins (4), saline extract (62, 98), potasssium thiOc:yanate (KSCN) 
extract (44, 75, 76, 77) and culture filtrate (9El, 97) have been 
studied. Although the immunogenicity of several of these preparations 
has been proved in experimental animals, identification of the 
protective factor(s) .resident in the various preparations.was not 
determined. 
The objective of this investigation was to characterize the 
biological activities of fractions of type A~ multocida. Specific 
aims were: (1) to identify and characterize inhibitory factors for 
. . ' .,· ... 
phagocytic cells present in the type A~ multocida capsule and 
determine its effect on specific aspects of bovine polymorphonucleat 
·1eukocyte (PMN) function, and (2) to evaluate immunogenicity of the 
KSCN extracts obtained from several P. mu;Ltocida straJns in mice apd . 
identify a protective component(s) in the KSCN extract on the basis of 
antigenic analysis •. 
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LITERA'IURE REVIEW 
Historical Background 
A disease process now known as pasteurellosis was reported long 
before the isolation of the causative microorganisms. During the 18th 
century, large epornitics in poultry were reported throughout European 
countries and were first studied in France by Chabert in 1782 (46). 
Maillet in 1836 termed the disease fowl cholera in connection with 
severe losses of fowl (46). 
Renault and Delafond, in the middle of the 19th century,. 
presented the first experimental evidence of the transmissibility of 
the disease by the injection of the infected blood, secretions and 
tissues to poultry (50). The presence of a bipolar ·staining, non-
m::itile organism in the blood of affected birds was first reported by 
Rivolta in 1877 and Perroncito in 1878 (50) __ • Toussaint confirmed 
these observations in 1879, was the first to isolate the microorganism 
' ' 
f~om. the blood of an affected chicken, and cultivated.it in 
neutralized urine (46). Pasteur in 1880 grew the organism in pure 
culture in chicken broth ;ma examined the_ virulence and inununological 
properties of the organism in chickens (511) • He observed that 
chickens which recovered from the disease or were inununized with aged 
live organisms, which were found to be avirulent for chickens, were 
protected against·a lethal challenge dose of fresh-cultured, virulent 
4 
live organisms. However, the immunity could be overwhelmed by a large 
challenge dose of bacterin. 
After isolation of the organism from birds, many investigators 
found that this organism was a very versatile pathogen capable of 
infecting cattle, buffalo, sheep, swine, rabbits, horses, cats, dogs, 
rats and mice (73). Moore in 1895 found the organism on the.mucous 
membrane of the respiratory tract of apparently normal cattle, sheep, 
swine, dogs and cats (19). The importance of· the organism in human 
infection was recently recognized in relation to infected animal bites 
(41) • 
The isolation of different strains by various individuals from 
multiple animal hosts and at different times resulted in a variety of 
terms being suggested to name this organism (73). Kitt in 1885 
suggested the term Bacterium bipolar multocidum to name the bipolar 
organism on the basis of its infectivity for a variety of hosts. 
Trevisan in 1887 used the name "Pasteurella" in honor of Pasteur and 
listed 3 species; P. cholerae-gallinarum, !'.· davainei and P. suilla. 
Flugge in 1896 related the organisms to species by names such as 
Bacillus boviseptica, Bacillus suiseptica and so on. These 
classifications represent the early tendency to form a species name on 
the basis of the affected host. In following this procedures in 
detail, Lignieres listed species names, such as Pasteurella bovine for 
wild animal, buffalo and cattle strains, !'.· aviaire for avian strains, 
P. ovine for sheep strains, P. porcine for pig strains, etc. Since 
all of the strains of the organisms isolated from the different 
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animals were so similar in their morphology and cultural 
characteristics, an inclusive name was suggested again as a 
consequence'of the trend to use one name for a·variety of strains. 
'11le name Pasteurella septica suggested by Tapley and Wilson in 1936 
was employed widely in sbrne European countries. The name Pasteurella 
multocida proposed by Rosenbusch and Merchant in 1939 (92) has 
acquired almost universal recognition at the present time. 
Characteristics of Pasteurella multocida 
I· 
AC:cording to the Bergey's manual (95), ~ multocida is a Gram-
negative facultative anaerobic bacterium with non-motile and bipclar-
staining properties. Organisms from infected animal tissues usually 
appear as coccobacilli or short rods (1.4 .:!:. 0.4 by 0.4 .:!:. 0.1 um). 
Strains isolated from healthy animals are often plepmorphic with 
longer bacillary forms and are occasionally filamentous. With 
electron microscopic examination of the organism, Brogden -(16) 
observed small spherical blebs on the surface of the cell and 
filamentous appendages which· closely resembled the structures present 
on Bordetella s~cies. ~ multocida can be diStinguished from other 
.Pasteurella species · (~ hemolytica, ~ pneumotrophica, ~ ureae) by 
the following characteristics: hemolysis on. blood agar -, growth on 
MacConkey agar-, indol +,and urease - (25). 
Many isolates of P. multocida possess a capsule which usually can 
6 
be detected by Jasmin's procedure, the Alcian blue method, India ink 
staining (25), or a negative staining method (16). The amount and 
chemical nature of the capsule seems to vary greatly from isolate to 
isolate. Carter's type A organisms possess the largest capsules which. 
are composed, to a large extent, of hyaluronic acid (26, 28) and give 
the colonies a mucoid appearance (26) • Sane type D E.• multocida also 
possess a hyaluronic acid capsule, but the amount is quantitatively 
much less. than type A .(29). Carter's type B and E organisms also. 
possess a capsule but the chemical nature is a glycoprotein rather 
than hyaluronic acid, an acid-mucopolysaccharide (5, 79). 
"IYPing Systems for Pasteurella multocida 
Methods for grouping and classification of P. multocida were 
extensively reviewed by Cornelius in 1929 (35), Cart~r in. 1967 (25) 
and Brogden in 1977 (16). According to the review by O:>rnelius, early 
workers tried to establish a serological classification of the 
bacteria· which corresponded to the zoolog.ical, grouping. Matsuda in 
.; . •' ' . 
1910 considered that a complement fixation test verified the 
zoological classification of pig, fowl, rabbit and calf strains. 
Miesser and Schern in 1910 found no agglutinatory relationsliip petweE!n 
~vine strains and other animal strains. Fitch and Nelso in ~923 could 
not demonstrate correspondence between a serological· and a zoological 
grouping. Tanaka in 1926 used complement fixation methods and 
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demonstrated the heterogeneous nature of the zoological groups in this 
respect. Lal in 1927 found some evidence of cross-reactivity among 
different animal strains using a complement fixation test. 
Cornelius (35) classified 17 of 26 strains into 4 groups using 
agglutinin-absorption tests and found no relationship between a 
serological group and the animal origin of the strains. In 1934, Ochi 
examined 72 hemorrhagic septicemia strains isolated from various 
species of animals and divided them into 4 groups on.the basis of 
serological, immunological and pathological properties (16) • Like 
Cornelius, he found that there was no relationship between his groups 
and the host of origin. 
Rosenbusch and Merchant in 1939 (92) identified 3 serologically 
distinctive types among 114 non-hemolytic Pasteurella strains by 
agglutinin tests and ability of the organisms to ferment xylose, 
arabinose and dulcitol. Little and Lyon in 1944 (65) confirmed the 
existence of 3 serologically distinct types within 30 non-hemolytic 
Pasteurella strains by passive immunization of mice and agglutination 
tests. They found that type specificity, virulence and host origin of 
these strains were unrelated. Roberts in 1947 (90) divided P. 
multocida strains into four groups, I, II, III and IV, on the basis of 
serum protection tests in mice. 
Carter (21) observed that P. multocida possesses a type specific 
capsular antigen, presumably polysaccharide in nature. He prepared 
the capsular antigen from several serologically distinctive strains of 
P. multocida by 2 methods: (1). Bacteria grown on an agar plate were 
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suspended in buffered saline and heated at 56 C for 1 h. After 
centrifugation, the bacterial pellet was discarded and the supernatant 
fluid was collected. (2). Bacteria grown on an agar plate were 
treated with 1 M sodium acetate and ethanol followed by subsequent 
extraction with phenol and saline. He also immunized rabbits and 
chickens with 0.25% formalized saline-treated bacteria to obtain the 
type specific antisera. By the use of the two extracted antigens and 
· type specific antisera in precipitation tests, he determined that 
there appeared to be a type specific polysaccharide antigen consisting 
of, or associated with, the capsule. Based on his studies, he 
identified 3 capsular types, A, B and C among strains of ~· multocida. 
An additional type D was demonstrated by Carter and Byrne (27) by the 
same methods. 
Carter (22) applied an indirect hemagglutination test for typing 
the bacteria. By the use of his capsular antigen preparations, immune 
sera and erythrocytes of human O blood type for the test, he found 
that this technique yielded highly specific reactions and had 
advantages over other typing methods. The type c.designation was 
subsequently dropped because of difficulties in recognition (23). An 
additional type E, which was isolated in central Africa and closely 
related to type B strains, was suggested later (24). 
Heddleston et al. (51) introduced a gel-diffusion precipitation 
test for serotyping avian isolates of P. multocida. They prepared !'.!_ 
multocida bacterins from 5 serologically distinctive strains (an 
extention of a proposal by Little and Lion) to immunize chickens for 
9 
the preparation of type specific antisera. Typing antigen was 
obtained from bacteria suspended in 0.85% NaCl solution containing 
0.3% formaldehyde and heated in a water bath at 100 C for 1 h. The 
supernatant fluid obtained by centrifugation of the suspension was 
designated a heat-stable.serotyping antigen. They found that the 
beat-stable antigen of one serotype reacted only with the homologous 
serum. On the basis of the experiments, they reported that at least 5 
different serotypes could be differentiated by this gel-diffusion test 
with heat-stable antigens. This serotyping system was further stud.ied 
(15, 52).and is now composed of 16 serotypes (16). 
Several non-serological typing methods for .specific serotypes of 
! 
P •. multocida strains· were suggested for .the support of the .preyious 
tzyillg.systems as well as for a rapid procedure. Carter and Annau 
(26) found that the capsule of type A strains contains a large aJ1Punt 
' ···, 
of hyaluronic acid which endows colonies with a mucoid appearance .• 
The mucoid appearance of the colony was changed by treatment with 
stapbyloccocal byaluronidase which depolymerizes the hyaluronicacid 
polymer of the capsule. By use of this method, type A strai_ns could. 
be identified non-serologically with staphylococcal hyaluronidase 
(28) • Carter and Suboronto (29) identified type D strains non-
serologically by the use of an acriflavine reaction that showed a . ' 
coarse flocculation only with type D strains in the slide 
agglutination test. 
Antigens of Pasteurella multocida 
Characterization of the antigenic structure of P. multocida has 
. -
proven difficult. The major differences in the antigenic structure 
·among various strains were found to be present in the capsules and 
cell walls of the organism (25). Characteristics of the capsules and 
cell walls varies with different conditions of growth. Certain 
antigens of the organism have been studied for the investigation of 
their serological and immunological nature as well as their role in 
·pathogenici ty. 
Carter and Annau (26) isolated capsular polysaccharides from the 
colonial variants of a type B P. multocida strain. The agar-<jrown 
bacteria were suspended in distilled water and heated at 56 C for 1 h, 
followed by centrifugation at 10,000 rpm. The supernatant fluid 
obtained by centrifugation was precipitated with 95% ethanol 
containing 0.25% sodium acetate. The precipitated polysaccharides 
from the fluorescent variant were found to induce a high level of 
protection in mice. Those of the mucoid variant were not pr.otective. 
When the surviving mice were challenged with strains of other 
serological types, ther.e was no protection. 
Yaw and Kakavas (102) isolated a capsular polysaccharide by the 
method of Carter and Annau (26) from an encapsulated type I strain 
(Little and Lyon) which was virulent for mice and chickens. They 
immunized mice and chickens with the capsular polysaccharide, the. 
heat-killed cells remaining after the saline extraction at 56 C for 1 
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h (20), and the heat-killed cells of an avirulent unencapsulated 
variant of the same strain. When the animals were challenged with the 
live virulent bacteria, the capsular polysaccharide was found to be 
protective in mice and chickens. However, the two heat-killed cell 
preparations could protect only chickens. They speculated that the 
• < 
protective antigen(s) of ~ multocida may differ in various animal 
species. 
Knox and Bain (61) extracted capsular polysaccharides from a P. 
multocida strain with 2.5% NaCl solution at 27 C for 2 h. This saline 
extract was found to be protective in mice. For the characterization 
of the extract, it was acidified with HCl to pH. 3.8, which yielded a 
precipitate. The precipitate was removed by centrifugation, and the 
remaining supernatant fluid was treated with excess ethanol, which 
yieled another precipitate. The nitrogen (for protein), fructose (for 
polysaccharide) and heptose (for lipopolysaccharide) contents as well 
as immunogenicity of the two precipitates were compared. The 
precipitate at pH. 3.8 contained predominantly proteins with some 
polysaccharides and lipopolysaccharides, and retained the ability to 
protect mice. The ethanol precipitate contained primarily 
polysaccharides with some protein and no lipopolysaccharide. Protein 
contamination of the ethanol precipitate was removed by treatment with 
trypsin. Mice were immunized with the purified ethanol-precipitated 
trypsinized polysaccharide. The purified polysaccharide was not 
protective in mice. However, this material could absorb some 
protective power from rabbit and cattle sera, which were obtained by 
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inununization of the animals with formalin-killed bacteria and had 
ability to completely protect mice following the passive immunization. 
Based on the results, they suggested that the polysaccharide was 
significant in immunity, although not exclusively so, because it could 
not remove all the mouse-protective power of the immune sera. 
Kodama et al. (62) extracted a capsular material from type A P. 
multocida by treating the organisms at 56 C for 1 h with 2.5% NaCl 
solution. 'lllis saline extract induced protective immunity in turkeys 
and chickens but, wh~n treated with cetylpyridinium chloride, the 
precipitated polysaccharide was not immunogenic. By continuing 
studies on the extract, Syuto and Matsumoto (98) demonstrated 
electronmicroscopically that the treatment of type AK· multocida 
cells with 2.5% NaCl solution removed the capsular material without 
disrupting the cells. 'llley fractionated the saline extract by gel-
filtration with a Sephadex G-200 column and 6btained 4 different 
peaks. 'llle protective ability of the 4 fractions was evaluated and 
detected only in the first peak. 'llley further purified the protective 
antigen present in the first peak by absorbing it onto DEAE-cellulose 
and eluting with a linear gradient of NaCl solution. A single peak 
which induced protective immunity in turkeys was further 
characterized. They found that the purified protective antigen had a 
carbohydrate/protein ratio of 1.5 and formed a single precipitin line 
with a rabbit antiserum against the original saline extract in gel-
diffusion and immunoelectrophoresis. Upon sodium dodecyl sulfate 
polyacrylamide gel electrophoresis, the purified antigen showed 4 
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bands. By isoelectric focusing analysis, it showed two bands. Each 
band of the isoelectric focusing analysis was isolated and used to 
innnunize turkeys. However, neither of the two components, alone or in 
combination, induced protection in turkeys. They could not explain 
why neither of the components induced immunity in turkeys. 
MacLennan and Randle (66) isolated lipopolysaccharides fran 3 
different serotypes of P. multocida by treatment of the bacteria with 
45% phenol, followed by centrifugation at 100,000 x g for 4 h. The 
precipitate was poorly soluble in water but was used in gel-diffusion 
tests. They also prepared type specific antisera by immunizing 
rabbits with the heat killed· bacteria of three serologically 
distinctive strains. Gel diffusion tests with homologous and 
heterologous type specific antisera indicated that the 
lipopolysaccharide showed at least one clear line of precipitation 
with hom::>logous antisera but none with heterologous antisera. 
Treatment of the lipopolysaccharide at 100 C for 1 h did not affect 
the formation of the precipitation line. Therefore, they suggested 
that the type specific lipopolysaccharide antigen would be useful for 
typing. 
Bain and Knox (6) treated their saline extract (61) with phenol-
water to extract a lipopolysaccharide. The extracted 
lipopolysaccharide was found to be lethal for rabbits at a dosage of 
500 ug when injected intravenously. Two week-old calves collapsed 2 h 
after receiving 300 and 700 ug respectively of the lipopolysaccharide 
but subsequently recovered. This lipopolysaccharide induced 20% 
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protection in mice against a homologous challenge. Antiserum, which 
was obtained from rabbits inununized with the killed whole cells and 
possessed abundant mouse-protecting antibody, could not passively 
protect other rabbits against the injection of 500 ug of the 
lipopolysaccharide. 
Penn and Nagy (79) reported that a capsular antigen of types B 
and E strains of P. multocida was type specific while the endotoxins 
of the two serotypes were not. Bacteria grown on the agar were washed 
off with 2.5% NaCl solution followed by centrifugation at 3,500 x g. 
The supernatant fluid was saved and the packed cells were treated with 
phenol-water as described by Westphal and Jann (99). Antisera were 
obtained from· rabbits that were inununized with the formalin-killed 
·bacteria. In the inununodiffusion test, two major antigenic components 
were foiind to be present in both the saline and phenol-water extracted 
preparations. The inununoprecipitation lines were fused indicating the 
extracts were antigenically similar. The saline extract of a non-
capsular variant lacked one of the precipitin lines, suggesting that 
this line was due to a capsular antigen. One percent sodium 
deoxycholate treatment of the saline extract altered the position of 
the non-capsular inununoprecipitin line. Since sodium deoxycholate 
breaks the endotoxin into smaller subunit, it was presumed that this 
line is due to the endotoxin. By the use of rabbit antisera, the 
extracts of both serotypes were compared by inununoelectrophoresis, 
The capsular antigen of the one serotype reacted only with the 
homologous antiserum, while the enotoxin reacted with both antisera. 
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Heddlesten et al. (54) isolated a particulate antigen from two 
virulent and serologically distinctive strains (X-73 and P-1059) of 
type A P. multocida. The agar-grown bacteria suspended in formalized 
saline solution. were incubated for 48 h at 4 c followed by 
centrifugation for 30 minutes at 12,000 x g. The supernatant fluid 
was filtered through a 400-mesh nylon cloth. The filtrate was 
·centrifuged for 2 h at 105,000 x g. A gel-like pellet obtained by the 
centrifugaion was washed and designated a particulate antigen. The 
particulate antigen possessed many of the properties ascribed to 
endotoxins. It was a high molecul&r weight, nitrogen-containing, 
phosphorylated lipopolysaccharide. Injection of 100 to 500 ug of the 
antigen intravenously into mice, rabbits or chickens produced severe 
effe_cts on thepe animals such as depression and· diarrhea; death 
followed. However, it protected almost 100% of the chickens and mice 
that.were given 2 ug of the particulate antigen against challenges 
with the live organisms. 
Rebers et al. (~5) isolated a particulate antigen from an 
encapsulated strain of type B P. multocida by the method of Heddlesten 
et.al. (54). This antigen was also found to have properties similar 
to those of the particulate antigen (55) of a type A P. multoeida 
strain. It was both toxic and protective in mice, rabbits and calves 
· depending on dose, .and similar to the endotoxin of P. multocida in 
chemical composition and toxicity. 
Crutchley et al. (36) first obs.erved an appreciable amount of 
toxic material, indistinguishable biologically from endotoxin, in the 
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culture supernatants of a wide variety of Gram-negative bacteria. 
Since this material contained primarily a lipopolysaccharide, it was 
referred to as free endotoxin. Rebers and Heddleston (84) compared 
the chemical and immunogenic properties of lipopolysaccharides (LPS) 
with free endotoxin isolated from a type A P. multocida strain. They 
prepared the LPS by the method of Westphal and Jann (99). The free 
endotoxin, which is secreted from or loosely bound to the surface of 
!'.!. multocida organism, was obtained by washing the agar-grown bacteria 
with cold 0.85% NaCl solution containig formalin followed by 
centrifugation and gel filtration on ~ Sepharose 2B column. The free 
endotoxin. induced active immunity in mice, but the LPS did not. 
Although the LPS and the free endotoxin both contained nitrogen, 
phosphorus, heptose and hexose, the fr.ee endotoxin had more nitrogen. 
Vigorous mixing of the free endotoxin or whole cell preparation wi.th 
50% phenol at .room temperature and subsequent dialysis to remove 
phenol resulted in complete loss of ability to induce active inimunity 
.in mice. Since mo~t polysaccharides are stable to phenol and most 
. . ' . 
proteins are irr~~ersibly denatured by it,, it would appear that some 
form of protein is necessary for the induction of active immunity· 
agains't P. multocida infection. 
Brogden and Rebers (17) examined the serologic specificities of 
the Westphal-type LPS isolated from 16 serotypes of P. multocida •. 
. They compared the LPS with the Heddleston's heat-stable typing antigen 
in gel diffusion tests. They found that the LPS from each of the 16 
serotypes reacted only with its homologous antiserum in 14 of the l~ 
17 
serotypes. Therefore, they concluded that the LPS appeared to be one 
of major antigenic components responsible for the type specificity. 
Rebers et al. (86) examined the serological and illi!lunological 
pr6pei:ties of a purified LPS antigen isolated from an·encapsulated 
strain of type A P. multocida. A crude LPS was obtained by the 
phenol-water extraction and contained nucleic acid, and capsular 
polysaccharides as well as LPS. The crude LPS was further purified by 
the treatment with RNase and DNase, followed by centrifugation at 
165,lillillil x g for 3 h. The purified LPS was fractionated in a cscl2 
density gradient centrifugation at 91il,lillillil x g for ?Iii h and 3 visible 
bands were obtained. The middle band contained most of the LPS. The 
crude LPS and the middle band (1 to llil ug) were used to immunize 
chickens to produce antisera. Passive administration of antiserum 
against the crude LPS protected 18% of the chickens. However, passive 
administration of antiserum against the middle band protected 86% of 
the chickens. Antisera obtained from the surviving chickens gave a 
single precipitation line in gel diffusion with the homologous. 
Heddleston's serotype antigen (16), and no reaction was obtained with 
any of the other 15 serotype antigens. Therefore, they concluded that 
~ multocida LPS is an important serological marker in Heddleston's 
typing system and antibodies induced against the LPS contribute to the 
protection of chickens. 
Bain (5) extracted a capsular protein-complex fraction from a 
type B ~ multocida strain by treating the .organisms with potassium 
thiocyanate (KSCN). 'lb a dense suspension of. bacteria in normal 
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saline there was added an equal voll.Dile of l M KSCN solution, followed 
by incubation at 37 c for 5 h. The bacterial suspension was 
centrifuged and the supernatant fluid was dialyzed against distilled 
~atet. This KSCN extract was found to be toxic for rabbits in a dose 
of 50 ug when ~njected intravenously. However, mice given l mg of the 
extract by· the same route were not affected. For mice, the KSCN 
extract was found to be an important antigen conferring active 
immunity in small doses and_· removing the protective power from an 
antiserl.DTI that was obtained from rabbi.ts immunized with heat-killed' · 
whole bacteria and possessing abundant mouse-protective antibody •. 
Mukkur and Nilakantan (77) confirmed the irnrnunogenicity of this 
' I 
,material in cattle •. 
Gaunt et al. (44) reported that the KSCN extract f_rom a serot~ 
3 (P-1059) .£.!. multocida strain was iinmunogenic in chi_ckens against a · 
challenge infection of the homologous strain as well as one 
heterologous strain tested (serotype 1, X73). Gel-diffusion analysis 
revealed the presence of two components which were antigenica;I.ly 
identical in KSCN extracts of both serotypes. 
Mukkur (75) immunized mice with the KSCN extract of P. hemolytica 
serotype 1. · These mice were found to resist a challenge infection of 
'.' 
a _type A P. multocida. strain, thus demonstrating cross-protection 
between species. This finding was further supported by the findillQ 
th.at P. multocida organisms could be killed by incubation with guinea 
pig complement and an antiser1.DTI directed against the KSCN extract of 
P. hemolytica, and vice versa. 
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Mukkur (76) compared the immunizing efficiency of the KSCN 
extract of a type A£ •. multocida strain with a formalin-killed P. 
multocida bacterin in mice. All of the mice immunized with the KSCN 
extract survived a challenge dose of 1.6 x 11<!6 cells. All of the mice 
immunized with the bacterin survived a challenge dose of 15 cells; the· 
survival rate decreased with increasing challenge dose. with a 
challenge dose of 1.5 x 103 cells, only 10% of the immunized mice 
survived. When combipation of KSCN extract and bacterin were used to 
immunize mice, the survival rate was no better than that of mice 
immunized with the bacterin alone. Ten times higher bactericidal 
titers were present in the sera of mice immunized with the extract 
cclmpared with those· given the bacterin. Three times higher titers 
were present in the sera of mice immunized ·with the extract compared 
·with those given the bacterin plus the extract. Based on the results; 
they suspected that immunosuppresion might conceivably be due to 
antigenic competition or partial denaturation of some vital prot~ctive 
antigen (s) as a result of for,malin treiltment.-
13hasin (10) tried to evaluate the immunogeni.city and tox,icity of 
a variety of antigens from a type A P. multocida strain such as, 
' . -
saline extract, fi:ee andotoxin, and phenol extracted endotoxin. The 
.saline extract possessed significant immunogenicity (70% protection) 
anq was non-toxic for mice. Free endotoxin in doses of 20 ug were 
highly immunogenic (100% pr'otection) in mice without the develoµnent 
of signs of toxicity. Higher doses (40 to 160 ug) were toxic but also 
highly immunogenic. The phenol extracted endotoxin was highly toxic 
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and non-imunogenic. An immunization trial with turkeys suggested that 
the free endotoxin was a better immunizing agent than heat-killed 
bacteria. 
Srivastava et al. (97) compared the immunogenicicty of the 
culture filtrate, cell walls and cytoplasmic components of a type A P. 
multocida strain, and tried to isolate a protective component(s) from 
the culture filtrate. The culture filtrate was prepared by 
centrifugation of bacterial cultures at 10,400 x g for 1 h followed by 
filtering the supernatant fluid through a 0.45 um membrane filter. 
The sediment obtained from the previous centrifugation was ruptured in 
a Ribi cell fractionator followed by centrifugation at 105,000 x g for 
1 h. The sediment was designated as cell wall and the supernatant was 
filtered through a 0.45 um membrane filter. The filtrate was 
designated as cytoplasmic components. Cell walls induced more 
protection in mice than cytoplasm or culture filtrate. They 
fractionated the culture filtrate on a Sephadex G-50 column and 
obtained 4 fractions. The first fraction was found to contain a 
protective material responsible for the protection of mice and was 
more immunogenic than cell walls. They indicated that this material 
is different from the free endotoxin studied by Heddlesten and Rebers 
,(53), because it had very low levels of 2-keto-3-deoxy-octanate (KOO) 
and heptose which are known principal chemical components of the 
endotoxin. Srivastava and Foster (96) continued to study the first 
fraction obtained from column chromatography. They treated it with 
ether to yield a "glycolipid-like" material and with phenol to yield a 
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"lipopolysaccharide-like" material. They found that the ether-
treated material was more ,protective for mice than the first fraction 
of the culture, filtrate. However, the phenol-treated material was not 
iimnUntigenic in mice and was toxic by rabbit skin tests. 
-Ganfield et al. (43) tried to purify a protective component(s) 
from the saline extract of a type A!'._. multocida strain. The starting 
material was obtained from the saline (0.85% NaCl containing 0.1% 
formalin) extract of P. multocida cells by differential centrifugation 
at 105,000 x g, and further purified by gel filtration on Sepharose 
2B. Three fractions were obtained after ge_l filtration. The first 
fraction consi'sted of 10_% of the starting material and was immunogenic 
' ' ' I . 
_iri mice (80% protection). The second fraction consisted of 75 _to 95% 
of -the starting material and induced active immunity in mice and 
. . ' ', , . 
turkeys-with the doses of 10 to 20 ug. Large doses were found _to be 
lethal. The third fraction was much less effective in inducing a 
protective illlllune response. 
Baba (4) .examined the immunogenicity of a ribosomal fraction 
isolated frbm a type A P. multocida strain. Organisms grol'in in a_ 
liquid medium were _harvested and washed by centrifugation. The packed 
cells were suspended in a tris-HCl buffer, pH 7.4, followed ~y'the _ 
rµpture in a French press. _The ruptured cellular mass was centrifµg_~ 
_at 8,000 x g for 40-min to remove whole cells, cellular debris and' 
cell walls. The supernatant fluid was further purified by 
differential centrifugation, zonal electrophoresis and gel filtration 
on a Sephadex G-200 column. The ribosomal fraction exhibited ~rttense 
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protective antigenicity in mice and turkeys. Sodium deoxycholate 
.treatment of the ·ribosomal fraction resulted in a 13% loss in 
' . 
immunological activity· and ribonuclease treatment caused a 69% lqss of 
the activity •.. Purified ribosomal protein or RNA ~ere not i~unogenic 
in mice. 
~· -
JUttigenic JUtalysis of Pasteurella multocida 
Although current studies have denonstrated that P. multoC:ida 
organisms are a serologically and .immunologically heterogeneous 
Si:1E!Cies, knowledge of the quantitative as well" as qualitative nature. .. 
of the antigenic components present in the var.ious immunogenic 
preparations, their probable nurnbE;?r and location, and identification 
of the protective or inhibitory component(s) is far from complete. 
'ltlere are only a few studies on. the antigenic analysis of ~ miiltocida . 
reported at present. 
Prince and Smith (89, 81 1 82) reported their series of antigenic. 
studies on P. nnlltocida. They prepared a variety of .. antigens such as, 
capsular extract, mickle disintegrate, sonic disintegrate, cellwall, 
• - • ' 1 ,. ' • 
i.soelectric precipitate at pH 3.8 and polysaccharide fraction.: 
.Mtisera were prepared by iillillunizing rabbits with whole killed - . ·, 
bacteria, disintegrated bacteria, capsular extract or cell wall. 
Using a standard electrophoresis system, up.to 18.antigens of a !>train 
of P. multocida were identified. When they examined the cross-
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reactivity P. multocida antigens with a variety of Gram-negative 
bacteria, .!'._· hemolytica was the most cross-reactive bacteria with 5 
' . 
cross-reactive' antigens. 
Baxi et al. (7) studied the antigenic structure of strains of 4 
carter's capsular types by ilnmunodiffusion and inununeelectrophoretic 
techniques. They found that at least 10 different antigenic 
components from the sonicated type A bacteria, 6 from type B, 3 fran 
type D and 7 from type E. However, the types could not be 
differentiated from one another by these techniques. 
Mukkur (76) reported that there were three antigenic components 
in the KSCN extract of a type A P. multocida strain by the use of 
I 
inununoelectrophoretic techniques and antisera obtained from mice 
inununized with the KSCN extract. 
Griffith (47) reported that differe,nt; bacterial fractions 
isolated from the same type A organism shared some of antigenic 
component(s) with each other. At least one or more (up to -7) 
antigenic components were identified from each fraction by 
inununodiffusion and inununoelectrophoretic techniques. 
Bhasin and L~ointe-Shaw (12, 13) examined the antigenic 
romplexities of type A P. multoc.ida by the use of crossed-
, - - ' ,, 
•" 
illllllunoelectrophoretic (CIE) teehniques. They P.repared a variety·of 
antigens such as whole cell,, disintegrate, cell envelope (saline 
extract),, KSCN e~ti:act, free endotoxin·, _and phenol-extracted 
lipopolysaccharide. They also prepared specific antisera against each 
antigen by inununizing r.abbits with the antigens •. The applicatiQn of 
\ 
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CIE to the analysis of f.• multocida antigens revealed antigenic 
complexity not: found before. They identified at least 55 antigenic 
i 
components in the cytoplasm, 19 in cell envelope, 5 in the capsular 
extract, 7 in the KSCN extract, 3 in the lipopolysaccharide, 3 in the 
heat-stable antigen and 5 in the free endotoxin. 
McKinney and. Rimler (74) examined the suitability ·of avian ant.i-
R!_ multocida serum for application in CIE techniques to detect· 
antigenic components of avian :P. multocida strains.. They found that 
0.05 M sodium 
1
acetate buffer at pH. 5.6 was the most suitable buffer, 
because avian antisera did not migrate at this pH, but migrated at pH . . 
8.6 which is riormally used in electrophoresis with mammalian sera •. 
' . 
Imnutjization of Cattle against Pasteurella Infection. 
' 
The. most prevalent bacterial species .found in the lurtgs of cattle 
with severe r~spiratory disease are f.· multocida and P. hemolytica 
(25, 32, 33, 45, 57, 58, 72). Since numerous attempt!; to develop 
. ' . -
successflJl ininunizing agents have failed_, bacterial pne~nia -due to. 
Pasteurella organisms is still a serious p.r;oblem in th.e cat:tle 
ii:idustry. 
Palotay et al. (78) tested several biological agents in an 
attempt to prevent respiratory infection in newly weaned beef caives. 
, I ' , '1\ • • " 
Of these agents, three agents that significantly reduced mortality 
were (l)· a conunercial hemorrhagic septicemia bacterin; (2) a bivalent· 
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bacterin· prepared from a p, multocida and a P. hemolytica strarns; and 
(3) a formalized bacterin prepared from chicken embryo-grown P. 
hemolytica which was isolated from cattle that died from acute 
pheuritonia. However,·there still remained 9.38% incidence of disease 
in the most effectively protected group when compared with 21.05% 
average for the control groups. 
Hamdy et al. (48) examined the efficacy of 5 different commercicil 
Pasteurella bacterins in young calves under field conditions. 
Although immunized calves showed as much as 500 times greater antibody 
titer than the controls, none of these bacterins effectively reduced 
the incidence of the disease. 
Larson and Schell (64) compared the toxicity of Paste.urella 
.baft,erins with their potential protective value in calves undergoing 
the stress of weaning and shipping. Calves given the bacterin 
developed significantly higher antibody titers than the controls. 
However, the immunized calves developed fever and leukocytosis with 
neutrophilia, although these effects were transient and did not . . . . 
clinically alter their general state of health .when c6mparec:'I with the. 
non-vaccinated controls. 
Bennett (9) examined the efficacy of commercial Pasteurella 
bacterins for yearling feedlot.cattle. He found that the mortality 
. . . 
. rate, though not statistically significant, was increased in 
vaccinated calves. 
Friend et al. (42) induced respiratory disease eicperimentally by 
the administration of the live ~ hemolytica organisms in calves ·· 
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vaccinated with .!'..!_ hemolytica bacterin and non-vaccinated controls. 
All the calves became severely ill about 2 to 6 h after the challenge 
with the. development of severe respiratory distress, abnormal lung 
sounds and coughing. Body temperature and total white blood cell 
counts tended to peak at 9 to 18 h with improvement or deterioration 
in clinical condition occurring subsequently. Calves with persistent 
signs of illness were killed at intervals, and the macroscopic and 
microscopic lesions of lungs were examined. The severity of the lung 
lesion were ranked. They found that the calves vaccinated with a P. 
hemolytica bacterin developed more severe pneumonia than the non-
vaccinated controls. 
Markham and Wilkie (71) reported a detrimental effect of !'.· 
hemolytica bacterin on bovine alveolar macrophages. They cultured the 
macrophages in Leighton tubes and added 125r-labeled .!'..!_ hemolytica 
with fetal calf serum or an immune serum that was obtained from calves 
immunized with .!'..!_ hemolytica bacterin. Tubes were then incubated at 
37 C for 2 h, after which coverslips were removed, washed in normal 
saline to remove unphagocytized bacteria, and placed in a gamma 
counter. Coverslips were stained and the number of the macrophages 
and bacteria was counted. The uptake of 1251-.!'..!_ hemolytica by the 
macrophages was significantly enhanced in the presence of the immune 
serum. However, the ratio of macrophages and bacteria adhering to the 
coverslips was significantly decreased. This indicated that the 
macrophages probably died after the uptake of the bacteria or at least 
lost their ability to adhere on the coverslips. In a separate 
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experimentation, they prepared Slcr-labeled macrophages and a culture 
supernatant of, P. hemolytica. When the culture supernatant was added 
to the culture: of the .slcr-labeled macrophages, the releas~ of Slcr 
was significarltly increased. Based on these. results, they concluded 
that the imnunization of cattle with .!::._ hemolytica bacterin may be 
detrimental to the macrophages of the host rather than protective. 
The detrimental components of .!::._ hemolytica on the bovine macrophages 
is probably a cytotoxin, which is released to the medium by P. 
hemolytica during culture or released to the phagocytic vacuole of the 
macrophage after ingestion of the bacteria. 
Due to the questionable efficacy and detrimental 'effects of 
·Pasteurella bacterins in cattle, man~ new approaches.for the 
preparc;ition of an effective immunizing agent have been proposed • 
. .r . ,. 
Chengappa and Carter (30) prepared live streptomycin-dependent (StrD) 
mutants from a streptomycin-sensitive type A P. multocida ·strain and a 
type 1 E_. hemolytica strain by treating the organisms with N-methyl-N-
nitro-NMnitrosoguanidine as a mutagen. They found that the mutants 
' -
were not pathogenic in mice while the wil~ types were pathogenic. In 
their continuing studies, Chengappa et al. (31) v~ccinated rabbits 
. ..· ' 
with the type A StrD mutant either by intran~al or subcutaneoiis 
admin~stration. Either method provided complete. protection against . ' 
hOllK>log?us, wild. type challenge as <;!Videnced by absence o.f clinical . 
. signs or pathologic changes and failure to isolate the organism from 
mucous secretions or tissues from the vaccinated individuals. 
Kucera et al. (63) developed a chemically·altered type AP. 
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multocida vaccinal strain (76-63M) by treatment with acridiniurn salts. 
This strain was found to be protective for mice and hamsters not only 
against a. hom:ilogous. challenge exposure,· but also against challenge 
exposure with a number of heterologous type A strains and a type B 
strain. This .strain was also found to be protective against the type 
B challenge exposures in calves, as·well as type A strains in swine 
and sheep. 
Wong and Kucera (100) used the chemically altered 76-63M strain 
to vaccinate mice and hamsters to find the cross-protectivity' between 
different capsular types of P. multoci.da strains. At least half of 
the mice and hamsters vaccinated survived against the challenge 
exposures with' type A and B strains. 
Cellular Immunity against Pasteurella multocida 
It has been generally considered that immunity to f.:_ multocida 
infection is pr.irnarily hurnoral in nature (34). Recently, it. has be,en 
suggested that cell-mediated immunity of the host against f.:_ multocida · 
infection may be as important as hurnoral immunity (68, 69, 70)o' The. 
cellular inmuni~y to this organism can be measured by lymphocyte 
blastogenesis ass~y in some cases. There is evidence that this 
organism can inhibit the cellular irnmunity of host. 
Maheswaran et al. (70) performed a lymphocyte blastogenesis assay 
using peripheral blood lymphocytes from turkeys that were imnunized 
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with a bacterin or left as non-inununized controls. They found that a 
higher stimulation was obtained with inunune lYl!'Phocytes than with non-
imnune lymphocytes. 
Maheswaran ~nd Thies (68) developed a whole blood lymphocyte 
stimulation assay to study cell-mediated inunune responses in bovine 
pasteurellosis. Peripheral blood lymphocytes from cattle immunized 
with·hemorrhagic septicemia strains (type Band E) of ~multocida 
exhibited higher stimulation indices when incubated with the antigens 
· of homologous serotypes than the heterologous shipping fever serotype 
(type A), and vice versa. Based on the results, theX suggested that 
lymphocyte stimulation a~say is useful for the measurement of cellular·· 
i'lUllune·respose of cattle against pasteurellosis and for the 
differentiation of strains of P. multocida isolated from cases of the 
different diseases. 
Maheswaran and Thies (69) examined the influence of encapsulation 
on phagocytosis of P~ multocida by bovine neutrophils by using two 
encapsulated strains, NA77 (capsular type A) and C42 (capsu1ar type . 
B), and one unencapsulated strain (1173). When they measured the 
uptake of [3H]thymidine-labeled bacteria in the presence of norJllCll 
bovine serl.Dll, the encapsulated strains iilhibited the phagocytic 
activity of .bovine neutrophils while the unencapsulated strain did 
not •. C42. (capsular type B) could be completely phagocytized by the 
neutrophils in the· presence of hyperinunune anti-C42 serl.Dll. However, 
only 3.8% of the NA77 (capsular type A) bacteria were ingested by the 
neutrophils. in the presence of hyperinmune anti-NA77 serl.Dll. When they 
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treated NA.77 organisms with bovine testicular·hyaluronidase, 90% of 
the decapsUlat~ organisms were ingested. ~¢refore·, they coriqluded 
that. the .factor asseciated with NA.77 organism which inhibited. the 
phagocytic activity of neutrophils was probab,ly hyalul::onic ~cid_which 
is a major component of the capsule of type A P. multocida •. 
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SECTION I. 
EFFECT OF TYPE A PASTEURELLA MULTOCIDA FRACTIONS ON BOVINE 
POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONSl 
Summary 
The effect of various Pasteurella multocida fractions on bovine 
polymorphonuclear leukocyte (PMN) functions was examined in vitro by 
using two encapsulated strains, P-2383 and P-1062 (both Carter's 
capsular type A and of bovine origin). The ability of PMNs to ingest 
Staphylococcus aur_eus and iodinate protein was significantly inhibited 
in the presence of live cells, heat-killed whole cells, or saline 
extracted capsule but not in the presence of the decapsulated heat-
killed cells. None of the fractions of the two strains inhibited 
nitroblue tetrazolium reduction by PMNs. The saline extract did not 
inhibit the binding of iodine to protein by a reaction involving 
xanthine, xanthine oxidase and horseradish peroxidase. The PMN 
inhibitory factor was further characterized as a heat-stable capsular 
material of greater than 300,000 molecular weight. 
1Published in Infection and Immunity, 1984, Vol. 43, p. 66-71 by 
H. Ryu, M. L. Kaeberle, J. A. Roth, and R. W. Griffith. 
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Introduction 
Pasteurella multocida is a major etiological agent in bovine 
respiratory disease (3,6), with capsular type A strains most 
frequently isolated in North America. Some encapsulated strains of P. 
·multoeida are known to be highly pathogenic in eicperimental animals 
_ and the· presence of the mucoid capsule is important for virulence 
(3,7). The capsule of type A strains is primarily composed of 
hyalutonic acid (4,5) which serves as a framework for the attachment 
of polysaecharides" proteins and ·lipids (3). 
'lbe importance of Pasteurellae in bovine respiratory disease has 
led to the .<'levelopment and use of various bacterial products for 
immunization. The efficacy and safety of most of these products still 
remains· in question (2,13,17,19). There is evidence that the' use of 
bacterins which are currently available may in fact be detriment!ll to 
the health of the animal (2,19). 
Recent studies on type A~ multocida ~apsular materials 
indicated that a KSCN extract (12,20) and a saline extr~ct (16,25) 
were protective against experimental challenge in mice, chiekens and 
turkeys. The capsule of a type A P. multocida has also been . . . - . 
demonstrated to inhibit the phagocytic activity of bovine neutrophils 
(18) .• Therefore, the capsule may con~ain not only a protective 
a~tigen but also a component which interferes with phagocytic cell 
function. It is not unusua_l for bacterial surface material to contain 
both a protective antigen and a virulence factor (B,9,14). 
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Phagocytosis of invading microorganisms by polyrnorphonuclear 
leukocytes (PMN) can be one of the major cellular defense mechanisms 
in protecting animals from microbial infection. Maheswaran and Thies 
(18) reported that an encapsulated type A ~ multocida (NA 77) 
inhibited the phagocytic activity of neutrophils (PMNs). When they 
measured the uptake of [3H]thyrnidine-labeled bacteria by PMNs, only 
3.8% of the encapsulated organisms were ingested. When the 
encapsulated bacteria were treated with bovine testicular 
hyaluronidase, however, 91i1% of the decapsulated organisms were 
ingested. They concluded that the factor which inhibited the 
j:>hagocytic activity of PMNs was probably hyaluronic acid which .is a 
major component of the capsule of type A~ multocida, 
The purpose of this experiment was to further characterize an 
inhibitory. factor present in type A~ multoc.ida capsule, and, 
determine its effects on specific aspects of PMN function. 
Materials and Methods 
Organisms 
'!Wo strains of Pasteurella multocida were used throughout this 
' ' 
study_ (P-2383 and P-llil62). Strain P-2383 was isolated from a case of 
bovine pneLD110nia presented to the Veterinary Diagnostic Laboratory, 
Iowa State University, Ames, IA. This isolate was a typical~ 
multocida strain; subsequent typing confirmed it to be a Carter's 
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capsular type A. Strain P-1062, also a type A and of bovine origin, 
is a challenge strain (IRP-198, National Veterinary Services 
Laboratory, U.S. Department of Agriculture, Ames, IA). Each strain 
was inoculated into the yolk sac of 6-:day-old embryonated chicKen 
eggs. Following incubation at 37 C for 18 h, the yolk material was 
c:iseptically removed and frozen in aliquots at -70 c. These aliquots 
were used as inoculum for preparation of bacterial fractions used in 
this study. 
-Bacterial fractions 
'.!he preparation of bacterial fractions is illustrated at Fig. 1. 
Infected yolk material was thawed, _inoculated on a 5% bovine blood 
agar plate and incubated at 37 c for 24 h. One. colony was transferred 
to 5 ml·of brain-heart-infusion (BHI) broth (Difeo LaboraJ:ories, 
Detroit, MI) containing 0.5% yeast extra,ct (Difeo) and 5% sterile 
bovine serum (BHISY) and incubated at 37 C for 4 h. This cult1,1re was 
then added to 100 ml of BHISY and incubated an additional 4 h. ·Roux 
bottles containing, dextrose-starch agar (Difcoi were inoculated with 
2.0 ml of BHISY culture and incubated at 37 C for 36 h. Cells were 
harvested by washing the agar surface with sterile phosphate-buffered 
' ' - ' 
!;alin~ solution. (PBS, pH. 7.2) and cell con9_entration was adjuste(j so 
' ,, . 
'that .a 10-fold qil~ti~n had an optical density (O.D.) of 0.4 at 540 nm 
(approximatly ·1.0 x.1010 cells/ml). The cells were washed three 
times in PBS and an ali~uot was saved for the "live cell fraction" 
(LCF). The remaining cells were washed one more time in PBS. , Cells 
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Agar-Grown P. multocida _____ _. 1010 C.F.U./ ml PBS 
( 10X, 0.4 0.D. at 540 nrn) 
l 
Washed 3 times 
i 
LCF.---.-- Live·Cells I packed) 
PBS 
1
2.5% Saline, 
56'C, 1Hr. 
plate count 
Dialysis in PBS 
Heat Killed Whole Cells -------.~KCF 
t 
+ Centrifugation 
+ Pellet Supernatant ! . Dialysis in PBS 
Saline Extract= SEF j Washed 3 Times and Resuspended in PBS 
Decapsulated cells= DCF 
Hyaluronidase 
37°C, 3 Hr. Filter thru 
"Amicon" PM300 Filter 
(Approx. 300K Cutoff) SEF·H 
Re'tentate:::: SEF-R Filtrate"" SEF-F 
l Hyaluronidase 37°c, 3Hr. 
SEF·RH 
Filter Thru 
"Amicon" PM300 Filter 
(approx. 300K Cutoff) 
Retentato =SE F-RH-R Filtrate= SEF·RH-F 
Autoclaved 
121°c, 15 Min. 
SEF-A 
Fig. 1. Preparation of bacterial fractions. 
'\ , ' 
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packed by·centrifugation were resuspended to. the original volume in 
N 
2.5% (wt/vol) sodium'chloride (NaCl) solution and placed in a water 
). 
bath at 5.6 C for 1 h. After this saline extraction, ;:m aliquot was 
saved for the prepar~tion of "heat killed whole cell.fraction". The 
remaii;ider was centrifuged at 17,3fiJfiJ x g for 2fiJ min at 4 c. The 
supernatant was saved and the pelleted cells were washed three;times 
'\ 
and resuspended with an equal volume of sterile· PBS. This preparation 
. ;~ 
'was designated the "decapsulated heat-killed cell fraction" (IJCF). 
i. 
'!tie heat-killed whole cell and supernatant fractions were dialyzed 
. ' 
against PBS for thre'e days 'to remove excess salt and used as the . 
"heat-killed whole cell" (KCT) and "saline extract" (SEF = l.fiJ~. mg dry 
weight/ml for P-2383 and fiJ.91 mg/ml for P-lfiJ62) fract'ions. Aliquots, 
" of _BEF were treated.various ways including: (1) treatment with bovine 
' •·I , 
testicular hyaluronidase (Sigma, Chemical eo·., St. Louis, MO., 1 mg of 
' . . 
'' 
hyaluronidase per ~ dry weight of SEF) by incubating in a water bath 
at 37 c for 3 h (SEF,H); (2) autoclaving at 121 C for 15 min (SEF-A); ,, 
(3) filtration with a 3fiJfiJ,fiJfiJfiJ molecular weight cutoff filter (Amicon 
Corp. Lexington, MA). The filtrate was designated SEF-F (fiJ.2fiJnig dry 
weight/ml for P-238~ and fiJ.25 mg/ml for P-lfiJ62) and Utilized directly. 
,The retentate was \'/ashed three times on the filtration membrane with 
PBS and designated as SEF-R (fiJ.94 mg dry ~eight/ml for P-2383 and fiJ.8fiJ 
mg/ml for P-lfiJ62). Control preparations of hyaluroriic acid (Human . 
umbilical cord, Sigma) and hyaluronidase (Sigma) at a ~oncentration.of, 
1 mg/ml.in PBS were prepared. The SEF-R of strain P;2383 was treated 
' 
with bovine testicular·hyaluronidase (Sigma, l'mg of,hyaluronida5e·per 
37 
mg dry weight of SEF-R of strain P-2383).and then filtered with a 
. ' 
300,000 molecular weight cutoff filter (Amicon). The filtrate was 
designated SEF-RH-F (0.80 mg dry weight/ml for P-2383 and 0.62 mg/ml 
for P-1062) and utilized directly. The retentate was. washed three. 
times as previ~usly described a~d desig~ated SEF•RH-R .(1.4.mg dry 
weight/ml for P~2383 ahd 0.98 mg/ml for p.:.1062)• 
PMN preparation 
. PMNs were isolated as previously described (23). Briefiy, 
peripheral blood from healthy adult cattle was collected in acid-
citrate-dextrose solution, centrifuged and the plasma and buffy coat 
layer were discarded. Erythrocytes in the packed cell fraction were 
lysed with distilled water and the remaining cells, which generally 
c6nsistea of greater than 90% granuloeytes, were washed and suspended 
in PBS to a concentration of 5.0 x 107 PMNs per ml. · The cells were 
held at ·room temperature and were used in all three PMN function 
tests. 
PMN function tests 
'Ihe procedures for.evaluating PMN functions have been described 
in detail (23). All PMN function tests were conducted in duplicate 
and the.average of duplicate values was used for calculation. 
(l)~ Staphylococcus aureus ingestion. Heat-killed 
. [1251] iododeoxyuridine ( [1251]UdR, Amersham Corp., Arlington Heights,. 
IL)-labeled S. aureus was used to evaluate ingestion by PMNs.. The 
38 
test was conducted in 12 x 7';1 nun plastic tubes and the standard 
reaction mixture contained 0.1 ml of [125I]UdR-labeled ~ aureus, 
0.05 ml of PMNs (2.5 x 106 PMNs, bacteria to PMN ratio = 60:1), 0.05 
mi of a 1:10 dilution of bovine anti-S. aureus serum and 0.3 ml of 
·Earle's balanced salt solution (EBSS, Grand Island Biological Co., 
Grand Island, N.Y). To determine the effect of bacterial fractions on 
ingestion by PMNs; 0.05 ml of a~ multocida fraction (5.0 x 108 cells 
or equivalent solution) or 0.05 ml of PBS as a control were added to 
·the standard reaction mixture. The reaction was allowed to proceed 
for 10 min at 37 C and the extracellular ~ aureus was removed by 
lysostaphin (Sigma) treatment, the PMNs washed by centrifugation and 
the amount of ~MN-associated radioactivity was determined. The 
results were e~pressed as the percentages of [125I]UdR•labeled ~ 
aureus that was ingested. 
Qh Nitroblue tetrazoliurn (NBT) reduction. This test was . 
conducted in 15 x 100 nun silicon-coated glass tubes and the standard 
reaction mixture contained 0.2 ml of NBT solution (2 mg/ml)·, 5.0 .x 106 
PMNs, 0.1 ml of preopsonized zyrnosan preparation (10 mg/ml) and 0.6 ml 
pf EBSS. To determine the effect of bacterial fractions on NBT 
reduction by PMNs, 0.1 ml of a~ multoc.ida fraction (1.0 x 109.cells 
or equivalent solution) or 0.1 ml of PBS as a control was added to the 
standard reaction mixture. After 10 min incubation at 37 C the 
reaction was stopped. The purple formazan formed by the reduction of 
NBT was extracted with pyridine and the optical density (O.D.) at 580 
nm was determined. The results are expressed as O.D. per 5.0 x 106 
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PMNs per 10 min in 5;0 ml of pyridine. 
Jll...!_ Iodination. The iodination test was conducted in 12 x 75 
nun polystyrene snap-cap tubes (#2058, Falcon,. Oxnard, CA). The 
Standard .reaction mixture contained 2.5.x 106 PMNs, 0.05 uci of 125r 
(Carrier free, Arnersharn Corp., Arlington Heights, IL), 40 rniiole of 
Na!, 0.05 ml opsonized zyrnosan (10 mg/ml) and 0.3 ml of EBSS. To 
determine the effect of bacterial fractions on iodi.nation by PMNs, 
0.05 ml of p, multocida fraction (5.0 x 108 cells or equivalent 
solution) or 0.05 ml of PBS as control was added to the standard 
reaction mixture. The reaction was allowed to proceed for 20 min at 
37 C and the amount of trichloroacetic acid (TCA)-precipitable 
radioactivity was determined. The res.ults are expresse4 as nanornoles 
of Na! per 107 PMNs per hour. 
Data analysis of PMN function test 
To determine the effect of bacterial fractions on each PMN 
function, the value obtained when a bacterial fraction was added to 
the PMNs was compared to the value obtained with control (PBS-treated) 
PMNs. An analysis of variance procedure was used to determine 
· significance of the differences in PMN function. For the graphic 
presentation of the data, all treatment values were. expressE!d as a 
percentage of the control. 
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Chemical analysis of bacterial fractions 
Total carbohydrate was determined with a phenol-sulfuric acid 
procedure (11) using glucose as a standard. Hyaluronic acid. was 
determined by the reaction of hexuronic _acid with carbazole (Sigma) 
and sulfuric acid (10) using D-glucuronic acid (Sigma) as a standard. 
Protein content was determined colorimetrically from the reaction of 
protein with Serva blue G dye (Serva Fine Chemicals, Inc., Long 
Island, N.Y.) using bovine serum albumin (Sigma) as a standard (21). 
xanthine-xanthine oxidase-horseradish peroxidase mediated iodination 
A chemical iodination procedure was f_orniulated following' the 
basic principle of PMN iodination (15,22). · Xanthine· (Sigma) was used 
as a substrate and xanthine oxidase (Sigma) served as the enzyme for 
the production of superoxide anion. Horseradish peroxidase (Sigma) 
was used to catalyze the i_odination reaction. !!'he standard mixture 
contained 40 rmoles Na!, 0.05 uci 1251, 0.3 ml of EBSS containing 0.1% 
bovine s~rum albumin, 0.5 mg xanthine, 0.5 unit of horseradish 
peroxidase and 0.05 ml of SEF or PBS as a control. The reaction was 
st;arted by the addition of 0.02 unit of xanthine oxidase. The mixture 
was incubated and proeessed by the same procedures as .used "for PMN 
iodination. A blank containing all components except xanthine oxidase 
was run with each experiment. Results are expressed in counts per 
minute. 
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Results 
Effect of P. _multocida fractions~~ aureus ingestion 
'Ib determine the effect of .!'..!. multocida fractions on phagocytic 
activity, PMNs were added to a standard suspension of opsonized ~ 
aureus in the presence or absence of P. multocida fractions. Control 
PMNs ingested 28.6 + 2.3 (mean + SEM) (n = 22) percent of the~ 
aureus in the reaction mixture. In the presence of I,CF, KCF and SEF 
of the two strains of .!'..!. multocida, ~ aureus ingestion was inhibited 
by 42 to 51% (Fig. 2). DCF had no. effect on~ aureus ingestion by 
PMNs. To further characterize the inhibitory factor, SEF was treated 
with hyaluronidas~, autoclaved or filtered through a 31iH!,000 M'1 cutoff 
. ' 
filter. Neither autoclaving nor treatment with hyaluronidase 
destroyed the inhibitory activity of SEF on ~ aureus ingestion by 
PMNS (Fig. 3). SEF-R did inhibits. aureus ingestion by PMNs by 41 j:o 
60% but SEF~F had no effect on the PMN ability to ingest ~ aureus. 
In a separate experiment· to further characterize SEF~R of strain~ 
' ' . '' ' 
2383, the control PMNs ingested36.l + 1~4 (mean+ SEM) (n = 8) 
0 • ' • - -
percent of the s. aureus in the reaction mixture. SEF-RH-R inhibited . . ---'-~ 
s~ aureus ingestion by PMNs by 59% but SEF-RH-F had· no effect on °the. 
-. - ' . . - .. '• ' " - ' 
Pt:!Ns ability to ingest. S. aureus (Fig. 7) • . S ~ aureus ingest ion by 
''' ' - --. · .. 
PMNs 'was.not inhibit€d by either hyaluronic ac~d or hyaluronidase. 'Ib 
determine if the_ inhibitory substance wa5 binding to the s. aureus or 
the PM!il, -the ~ au~eus ingestion assay· was per~()rmed using ~ aureus 
and PMNs_ )'ihich had been separat.ely treated .with P-23B3 SEF.:..RH-R by 
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Fig. 2. Effect of type A.!'..!_ multocida fractions on~ aureus 
ingestion by bovine PMNs. values represent mean (2: SD) 
percentages of the control value. Statistically significant 
differences from the control value are as indicated. **, p < 
0.01. *, 0.01 < p < 0.05. n = 16 for the saline·extract 
fraction (SEP) and n = 6 for all other fractions. 
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Fig. 3. Characterization of the inhibitory activity in the saline 
extracted fraction on £:.. aureus ingestion by bovine PMNs. 
Values represent mean (±_ SD) percentages of the control 
value. Statistically significant differences from the 
control value are as indicated. **• p < 0.01; n = 6 for all 
fractions. 
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incubating for 20 min at 37 C in a shaking water bath, then washed 3' 
times with PBS. The results in Table 1 indicate that the inhibitory 
substance was rem::>ved by washing and did not bind to either t:he·PMN or 
the ~ aureus •. 
Effect of P. multoc1da fractions oh NBT reduction 
'lb study the effect of~ multocida fractions.on oxidative 
metabolisni of PMNs, the ability of PMNs to reduce NBT by the 
production of superoxide anion in the presence or absence of the 
bacterial fractions was determined. NBT reduction .by =ntrol: PMNs wa5 
0.47 + '1).01 (mean + SEM) (n = 15) O.D. at 580 nm. None of the - ' - -
J=ractions of the two type A strains significantly (p > 0.05) affected' 
! 
.NBT reduction by PMNs (Fig. 4). 
Effect of P. multocida fractions on iodination 
'lb study the effect of ~ multocida fractions on the 
Jl\Yeloperoxidase~H2p2-halide antibacterial system of th~ PMN the 
ability of PMNs .to iodinate protein in the presence or abs~nce of the 
bacterial fractions was determined.· The value for iodination by .. 
control PMNs was 42.3 +.2.2 (mE!an + SEM) (n = 22) nm::>les Na! Per 107 
. ·- - '· 
PMNs per hour. The ability of PMNs to iodinate protein in·the 
. presence of I.CF, KCJ;' and SEF of the two strains was inhibited 30 to 
36%, but DCF had no effect on iodination.by PMNs (Fig. 5). When SEF 
was processed for further characterization of the inhibitory factor as 
described for the s. aureus ingestion assay, neither autoclaving nor 
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Table 1. The effect of preincubation of PMNs and s. aureus with P-- ' 
2383 SEF-RH-R on the ingestion of~ aureus by PMNs. Values 
represent the percents of radio-labeled ~ aureus ingested 
by PMNs with various treatments 
~-----------------------------------------------------~-------------
Pretreatment (followed 
by washing) 
Bacterial fraction added to 
reaction mixture 
None SEF-RH-R 
---------------------------------------------------------------------
None 29.8 + 3.3a 19.9 + 1.8 
s. aureus preincubated with 
SEF-RH-R 27.1 + 2.1 17.6 + 2.4. 
PMNs preincubated with 
SEF-,RH-R 31.8 + 4.4 i,21.2 + 4.8 
Both s. aureus and PMNs ., 
preincubated with SEF-RH-R 29.8 + 3.1 23.4 + 2.4 
-----------------------------------------------------~------------· -
a Mean+ standard error (n = 6). 
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Fig. 4. Effect of type A~ multocida fractions on NBT reduction by 
bovine PMNs stimulated with opsonized zymosan. Values 
represent mean <.±. standard deviation) (n = 6) percentages of 
the control value. None of the differences are statistically 
significant (p > 0.05). 
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Fig. 5. Effect of type A~ multocida fractions on iodination by 
bovine PMNs stimulated with opsonized zymosan. Values 
represent mean percentages (:~ standard deviation) of the 
control value. Statistically significant differences Eran 
the control values are as indicated. **, p < IL 01. *, 0. 01 
< p < 0.05. n = 16 for SEF and n = 6 for all other 
fractions. 
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treatment with hyaluronidase destroyed the inhibitory activity of SEF 
on iodination by PMNs (Fig. 6). SEF-R inhibited iodination by PMNs by 
35 to 49% and SEF-F did not. In a separa~e experiment to further 
characterize SEF-R of strain P-2383, the value for iodination by 
control PMNs was 37.8 + 1.6 (mean :t SEM) (n = 8) nmoles Na! per 107 
PMNs per hour. SEF-RH-R inhibited iodination by 70% and SEF-RH-F had 
no effect (Fig. 7). Iodination by PMNs was not inhibited by either 
hyaluronic acid or hyalur.onidase. 
Titration of the inhibitory activity of the bacterial fraction 
P-2383 SEF was used to evaluate the concentration effect of the 
bacterial fraction on s. aureus ingestion and iodination by PMNs. The 
inhibitory activities were concentration dependent, but neither was 
completely inhibited even at the highest concentration of the 
bacterial fraction (Fig. 8). 
Chemical analysis 
'The results of chemical analysis of the bacterial fractions are 
shown in Table 2. 
Effect of the saline extracted capsule on xanthine-xanthine oxidase-
horseradish peroxidase mediated iodination 
To further study the effect of SEF on the iodination reaction a 
chemically mediated iodination reaction was used which did not. involve 
Pr.<Ns. Xanthine and .. xanthine oxidase were used to generate superoxide 
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Fig. 6. Characterization of the inhibitory activity of the saline 
extract fraction on iodination by bovine PMNs. Values 
represent mean percentages (± SD) (n = 6) of the control 
value. Statistically significant differences frcm the 
control value are as indicated. **, p < 0.01. *, 0.01 < p < 
0.05. 
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Fig. 7. Characterization of the inhibitory activity of the saline 
extract fraction of strain P-2383 on s. aureus ingestion and 
iodination by bovine PMNs. Values represent mean percentages 
(+ standard deviation) of the control value. Statistically 
significant differences from the control value are as 
indicated. **, p < 0.01. *, 0.01 < p < 0.05. n = 8 for all 
fractions. 
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Fig. a; The effect of various concentrations of P-2383 SEF on s. 
aureus ingestion and iodination by.PMNs (n = 6). 
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Table 2. Chemical analysis of P-2383 bacterial fractions 
-----------------------------------------------------~----------------
Fraction Concentration Carbohydrate Hyaluronic acid Protein 
(mg dry weight/ml) (mg/ml) (mg/ml) (mg/ml) 
~~-------------------------------------~--------~-~-~--~~------
SEF 
SEF-R 
SEF-RH-R 
SEF-RH-F 
1.06 
0.94 
1.40 
0.80 
0.38 
0.33 
0.35 
0.26 
0.17 
0.17 
0.12 
0.04 
0.07 
0.06 
0.25 
0.22 
--------------------------------------------------------------------~ 
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anion which spontaneously forms hydrogen peroxide. Horseradish 
peroxidase was used to catalyze the hydrogen peroxide-halide reaction. 
SEF did not inhibit the xanthine-xanthine oxidase-horseradish 
peroxidase iodination system (Table 3). 
Discussion 
Polymorphonuclear leukocytes are important in protecting anim~ls 
from microbial infection by their phagocytic activities. According to 
Root and Cohen (22), two major microbicidal events occur. inside the 
PMN when a microorganism is ingested: (1) the generation of highly 
t()xic .. products of oxygen by the oxidative metabolism and (2) the 
enzymatic destruction and digestion of the micrdorganism by the 
lysosomal enzymes present in the intracellular granules which fuse 
with the phagocytic vacuoles. However, many pathogenic microorganisms 
have developed mechanisms to inhibit phagocytic cell activity to 
facilitate their survival in the host (9). 
The ingestion of bacteria is the first step in the bactericidal 
activity of the PMN. The resu~ts of the ~· aureus ingestion assay 
.indicate that the capsule of type A~ multocida inhibits the ability 
of PMNs to ingest particles. When bacterial fractions containing 
whole organisms were used, the inhibition of ingestion of~ aureus 
may have been due to competition between the two bacterial species. 
However, when soluble bacterial fractions were' used, competition for. 
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Table 3. The effect of the saline extra.cted fraction (SEF) of type A 
P. multocida on xanthine-xanthine oxidase-horseradish 
peroxidase mediated iodination 
------------------~-------------------------~-~--------------------
Bacterial fractions Iodination value (cpm)a· 
--------------------------------------------~---------------------~ 
Blank (no xanthine oxidase) 245 + 18 
Control (PBS) 1466 + 129 
·SEE' of strain P-2383 1453 + 78 
' 
SEE' of strain P-1062 1502 + 89 
---------------------------------------------------------------------
a Mean + SEM of eight experiments.· The differences from the 
=ntrol value .are n(Jt statistically si~nificant (p > 0.05). 
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ingestion should not have been a factor. In addition, the results in 
Table 1 indicate that the inhibitory activity was .not retained after 
washing of pretreated PMNs or bacteria. Apparently, ·this substance 
has an effect on PMN metabolism which is reversible and is not 
mediated through binding to a high affinity receptor. The mechanism 
of action of this material is not known and is the subject of further 
investigation •. Maheswaran and Thies (18) reported that removal of the 
capsule from type A~ multocida (the same capsular type used in this 
experimentation) with hyaluronidase enabled PMNs to ingest the 
·decapsulated organisms. They speculated that the inhibitory substance 
was hyaluronic acid. The r.esults reported here, however, indicate 
that hyaluronic acid per se is not responsible for the inhibition of· 
PMN function. Hyaluronic acid isolated from human umbilical cord did 
.not suppress PMN function. Thus, the repeating disaccharide (D:-
glucuronic acid and N-acetyl-D-glucosamine) backbone structure of 
hyaluronic acid, which would be common between.the hyaluronic acids pf 
humari and bacterial origin was not responsible f~r the inhibition of 
. . ' " '. ;, . , ·., . 
PMN function. It is· possible that the PMN. inhibitory subStance ·is. 
' ' 
:.structurally linked to the bacterial hyaluronic acid. The ~reatmeqt ~ .. .-: .. 
• • I > •' -·' • ' '; ," ,: ," '· ' ;- • • 
of the caps4lar mate~ial with hyaluronidase did. not destroy\he 
inhibitory faqtor. The hyaluronidase treatment did destroy the mqcoid 
' . . ' . 
vi.scous !'lature of the SEF. Even after· hyaluronidase treatment t\lere 
was st.ill some glucuronic acid (a component of hyaluronic acid) which 
did not. pass through· the ~00 ,000 MW. cutoff membrane.. Since hyaluronic 
acid of the P. multocida capsule serves as a framework ·for other 
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nolecules (3), there may be a variety of chemical components attached 
to hyaluronic· acid which would not be degraded by .the hyaluronidase. 
These molecul_es may be large enough to retain associated glucuronic 
acid from passing through the 300,000 MW cutoff membrane. The 
hyaluronic acid fragments which did pass through the membrane (SE:F-RH-
F) did. not inhibit PMN function. 
Oxidative metabolism of the PMN is an important aspect of its 
bactericidal activity (22). When a PMN receives the proper stimulus, 
an oxidase enzyme on the surface of the plasma membrane or phagosomal 
membrane will catalyze the conversion of oxygen to superoxide anion. 
Superoxide a.nion spontaneously dismutates to hydrogen peroxide. NBT 
is directly reduced by the superoxide anion to an insoluble purple 
·formazan (26). NBT reduction is therefore a measure of superoxide 
anion generation by the PMN. Since NBT reduction was not· inhibited by 
whole bacteria or.bacterial fractions (Fig. 4), type A.!:!_ multocida 
apparently does not inhibit the production ~f superoxide anion by the 
PMN. 
The iodination reaction is a measure of .the ability of the PMN ·-to 
convert inorganic iodide to a '!'CA-precipitable (protein-bollnd) form 
and occ::urs inside the phagocytic vacuole via the action of hydrogen 
peroxide and myeloperoxidase. This system has been found to exhibit a 
marked toxic activity toward bacteria, fungi and viruses (1,24). The 
iodination reaction by PMNs is dependent upon the generation of 
hydrogen peroxide, degranulation to release myeloperoxidase, the 
presence of iodine, the unimpaired.ability of myeloperoxidase to 
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catalyze the reaction, and the presence of tyrosine to bind iodine. 
Hydrogen peroxide is formed spontaneously from superoxide anion. 
Since SEE' did not inhibit NBT reduction, superoxide anion generation 
by PMNs is apparently not affected by the. inhibitory factor. Since 
the xanthine-xanthine oxidase-horseradish peroxidase mediated 
iodination was not inhibited by SEF, the rate of formation of hydrogen 
peroxide from superoxide anion and the rate of hydrogen peroxide 
destruction were apparently not affected. In addition, the ability of 
the peroxidase enzyme to catalyze the reaction was apparently not 
impaired. It must be kept in mind that horseradish peroxidase and 
rnyeloperoxidase are different enzymes. It is possible that the 
inhibitory factor could inhi~it myeloperoxidase directly without 
inhibiting horseradish peroxidase, but· this does not seem likely. 
This experimentation demonstrated that phagocytosis and protein 
iodination by PMNs were inhibited in the presence of whole P. 
multocida organisms and bacterial fractions. Since the rernoval of the 
capsu.le removed the inhibitory capability, the inhibitory activity 
apparently resides in the capsule or surface structure of .the 
bacterial cell. The inhibitory factor is a heat-stable, saline (2.5%, 
wt/vol)-extractable capsular material of greater than 30'0',0'0'0' 
molecular weight.. The inhibitory activity can not be attributed to 
hyaluronic acid, but it may be structurally associated with it. 
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SECTION II • 
. ·IMMuNOGENICITY OF POTASSIUM THIOCYANATE EXTRACT 
OF TYPE A PASTEURELLA MUL'IOCIDA 
Surninary 
Irrmunogenicity and cross-protectivity of potassium thiocyanate 
(KSCN) extracts from type A Pasteurella multbcida (~multocida) 
strains were evaluated in mice. Mice immunized with KSCN extracts 
from several ~ mult0cida strains showed signs of depression for 
several. hours after immunization but protected against challenge with 
the virulent homologous bacteri\Jm. Some of the mice died and many of 
the surviving mice were clinically ill up to 72 h after challenge 
exposure~ but gradually recovered •. However, there was no consistent 
reciprocal protection between different strains of a serotype 
indicating nci correlation between serotype and cross-protection·of 
mice. Antigenic analysis of KSCN extracts of type A P. multocida by 
crossed:-immunoelectrophoresis techniques revealed at least 25 
' ' 
different antigenic components. When the antigenic.contents of P-2383 
and P-1062 KSCN extracts were compared, most antigenic components were 
common to both. TWo antigenic components appear.ea to contain a 
I 
! 
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strain-specific antigenic determinant which could be identified only 
with the homologous system. One component present in each of the 
extracts gave a precipitation line similar to that associated with a 
crude lipopolysaccharide extracted from the organism. This component 
was isolated by sucrose density gradient centrifugation. The 
component isolated from P-2383 KSCN extract sedimented rapidly 
I 
indicating a high molecular weight material which contained 12% 
carbohydrate and 27% protein. Immunization of mice with this 
.component demonstrated resistance to challenge with the homologous 
strain and some degree of protection against certain heterologous 
strains. 
Introduction 
Capsular type A strains of Pasteurella multocida are known to be 
a major etiologic factor in important animal diseases such as fowl 
cholera in chickens and turkeys, and pneumonic pasteurellosis in . 
cattle (11, 14). 
The importance of the organism has led to the development and use 
of various bacterial preparations, either conunercial or experimental, 
for immunization. .Such bacterial preparations include killed 
bacterins (5, 6, 10, 18, 20, 24, 29), live attenuated or mutatea 
vaccinal strains (7, 12, 13, 23, 25, 39) and isolated cellular 
fractions· (2, 3, 4, 9, 16, 17, 22, 26, 27, 28, 31, 32, 33, 34, 35, 36, 
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37). Experimental findings indicated that animals immunized with many 
of these preparations were protected against challenge infection with 
the virulent homologous strain, and in some cases with strains of 
different serotypes. However, identification of the protective 
factor(s) resident in the various preparations was not determined and 
limited experimentation has been conducted on the immunogenic 
relationship between different strains of the same serotype. Due to 
the lack of scientific evidence on the nature of protection against !'.:_ 
multocida infection, the efficacy and safety of these preparations 
still remains in question. 
Recently, potassium thiocyanate (KSCN) extracts of type AP. 
multocida have been reported to demonstrate immunogenicity· in 
experimental animals hot only against the homologous strain (3, 27, 
28) , but also against strains of different serotypes (17) and even 
against a different species, !'.:_ hemolytica (26). The objectives of 
this experimentation were to evaluate the iriununogenicity and cross-
reactivity of KSCN extracts from several different type A!'.:_ multocida 
strains in mi~e, and to identify the protective ,component.Cs) of the' 
extracts on the basis of antigenic analysis. 
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Materials and Methods 
Organism5 
Six strains of ~ multocida were used in this study: P-1062, P-
2383, P-92481, P-03894, P-8103889 and P-813310. Strain P-1062, a 
capsular type A and somatic type 3, is a standard challenge strain of 
bovine origin (IRP~l98, National Veterinary Services Laboratory, U.S. 
Department of Agriculture, Ames, IA). The other five strains were 
isolated from cases of bovine pneumonia presented to the.veterinary 
Diagnostic Laboratory, Iowa State University, Ames, IA. With one 
exception, these isolates were related on the basis of serotyping as 
surmnarized in Table 1. Each strain was inoculated into the yolk sac 
of 6-day old embryonated chicken eggs'. Following incubation at 37 C 
for 18 h, the yolk mater.ial was aseptically removed and frozen in 
aliquots at -70 C. For the preparation of bacterial fraction.s, the 
infected yolk material was thawed, inoculated on a 5% bovine biood 
agar plate and incubated at 37 C for 24 h, One colony was transferred 
to 5 ml of brain heart infusion broth (BHI, Difeo Laboratories, 
Detroit, MI) with 0.5% yeast extract (Difeo) and 5% sterile bovine 
serum (BHISY), and incubated at 37 C for 4 h. ·This culture was then 
added to 95 ml of BHISY and incubated· an additional 4 h. When the 
bacterium were grown in large volumes (5 liters) of liquid medium, 100 
ml of BHISY culture were added to the medium and incubated an 
additional 18 h with a 5% co2 aeration. When organisms were 
cultivated on solid media,· Roux bottles containing dextrose starch 
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agar (Difeo) were inoculated with 2 ml of the BHISY culture and 
incubated at 37 C for 36 h. 
Bacterial fractions 
Bacterial· fractions of f!_ multocida were prepared by several 
procedures including KSCN extract, whole cell, .ribosomal.protein and 
lipopolysaccha~ide. 
KSCN extracts from all 6 strains were prepared by the method of 
Mukkur (27) with slight modifications. Briefly, f!_ multocida 
organisms grown at 37 C for 36 h in Roux bottles were harvested by· 
suspending the. bacteria in 111.5 M KScN (Fisher Scientic, Fairlawn, NJ) 
containing 111.1118 M NaCl. The bacterial suspension was incubatea in a 
shaking water bath at 37 C for 5 h and centrifuged at 17,3111111 x g for 
3111 min.· The supernatant fluid was filtered through a 111.9 um membrane 
filter (Gelman Instrument Co., Ann Arbor, MI). The filtrate was 
dialyzed against 111.32 M NaCl/111.1111 M tris-HCl buffer (Sigma Chemical 
Co., St. Louis, MO) at 4 C for 5 days with the buffer changed twice a 
.day. To reduce the.viscosity of ~he preparation, bovine testicular 
hyaluronidase (Sigma, 1 mg of hyaluronidase per 1111 mg dry weight of 
KSCN extract) was added and the mixture was incubated in a water ba~h 
at 37 C for 3 h. 
Whole cell fraction was prepared from two strains (P-2383 and P-
111162). Each strain was grown in BHISY at 37 c for 18 hand harvested 
by centrifugation at 8,111111111 x g for 3111 min.. Cells were washed with 
sterile phosphate-buffered saline (PBS) solution, pH. 7.4, and 
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Table 1. Serotypes of several bovine isolates of P. multocida 
-----------------------------------------------------------~ 
Strain 
Serotype 
Somatic : Capsular 
---------------------------------------------~---------------
P-1062 3 A 
P-2383 3 A 
P-813310 3 A 
P-8103889 3, 4 :A 
P-92481 .3, 4 : Untypable 
P-03894 12 : Untypable _____ ;..; __________________ .._ __________________ .;;,;, ________________ _ 
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resuspended in 0.01 M Tris-HCl (Sigma) buffer containing 5 x 10-3 
MgC12• Cells were disrupted in a Ribi cell fractionator (Ivan 
Sorvall, Inc., Newton~ CT) and this preparation was used as the whole· 
cell fraction (WC) • 
Ribosomal protein fraction was prepared from two strains (P-1062 
and P-2383) by the method of Baba (2). Briefly, cellular debris were 
removed from the WC fraction by centrifugation at 27,000 x g for 1 h 
at 5 c. The supernatant fluid was centrifuged again at 65,000 x g for 
l h at 5 c. The pellet was discarded and the supernatant was passed 
through a 0.45 um membrane filter (Falcon Plastics, Los Angeles, CA). 
'!he filtrate was centrifuged at 108,000 x g for 3 h at 5 c, and the 
supernatant was termed the ribosomal protein fraction (RP). 
Phenol-extracted endotoxin was prepared from two strains (P-2383 
and P-1062) by a modification of the method.of Westphal and Jann (38). 
Cells were grown in BHISY at 37 C for 18 h and harvested by 
centrifugation at 8,000 x g for 30 min. The cells were washed 3' times 
in sterile PBS and resuspended in sterile distilled water. The cells 
were mixed for 8 min in a Waring blender with 2 volumes of phenol at 
25 C and centrifuged at 4,000 x g for 20 min. The aqueous phase was 
,removed and the remainder re-extracted with a volume of distilled 
water equal to the volume of .the original cell suspension. The 
aqueous phases w~re combined and dialyzed exhaustively against 
distilled water at 5 c. 
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Determination of lethal dose 
Before the challenge experiments, the lethal dose (LD5~) of . .!'..!_ 
multocida strains for mice was determined. Bacterial suspensions were 
adjusted spectrophotornetrically and appropriately diluted (10 to 104 
bacteria per 0.1 ml, as determined by direct plate =unting). The 
LD50 of P-1062, P-2383 and P-8103889 for mice was less than 10 
bacteria while the LD50 of P-813310 and P-92481 was less than 100 
bacteria. However, the latter two strains did not· kill all the mice 
at a dose of ~04 bacteria. Strain P-03894 was not pathogenic for 
mice. 
l\buse inununization and challenge 
White Swiss mice (Sasco Inc., Omaha, NE) of one sex were utilized 
for inununization and challenge.experimentation. At the time of 
inununization, the mice weighed 12 to 15 grams. All mice were 
inununized subcutaneously with 0.1 mg (protein =ncentration) of 
antigen and challenged intraperitoneally 3 weeks later with 0.1 ml of 
bacterial suspension. Mice were observed for one week after challenge 
and deaths r.e=rded. 
Production of antisera 
Bacterial fractions (WC, RP and KSCN extract) of sttains -P.,.1062 
and P-2383 were used for inununization of rabbits. Twenty-tWC> New 
Zealand white female rabbits were randomly divided into two groups of 
11 rabbits. Each group was further divided into three subgroupsi 3, 
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5, and 3 rabbits for immunization with WC and RP fractions and KSCN 
extracts of the two strains respectively. Each bacterial fraction (5 
mg of protein content per ml) was mixed with an equal volume of 
Freund's complete adjuvant for primary immunization, or with an equal 
volume of Freund's incomplete adjuvant for the subsequent 
administrations. Rabbits were immunized with one ml of the primary 
irnmunogen preparation subcutaneously in 6 different sites on the back. 
Animals received one ml of the booster immunogen preparation at 
monthly intervals. Sera were collected after the third booster 
injection, divided in aliquots and stored at -70 C. 
Irranunoelectrophoresis 
Crossed immunoelectrophoresis (CIE) , CIE with intermediate gel, 
tandom CIE and fused rocket immunoelectrophoresis were performed in an 
LKB multiphor system (LKB-Produkter AB, Brornma, Sweden) according to 
published procedures (1). Briefly, agarose prepared from commercial 
tablets (Bio-Rad Laboratories, Richm6nd,. CA., 1%: 1 tablet per 5 ml of 
water) dissolved by heating in deionized water'was used in both first 
and second dimensional electrophoresis. CIE in the first dimension 
was perf9rmed on a 10 cm x 10 cm glass plate. The plate was covered 
with 2 mm thick agarose. gel. After gelling and cooling at room 
temperature, 4 antigen wells were punched out 2 .cm apart in a line 3.5 
cm from the cathodal end. For tandem CIE, a second well was punched 
out about 5 mm to the right and 5 mm below the first well. Antigens 
were applied to each well and electrophoresis was performed at 10 C 
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for 1.5 h at 200 volts in a water cooled electrophoresis chamber 
filled with tricine buffer (Bio-Rad, pH. 8.6). CIE and tandom CIE in 
the second dimension were performed on a 12.5 cm x 26 cm plastic plate 
(LKB)• The actual space to be covered with agarose gel was limited to 
10 cm x 24 cm by the use of brass bars. Agarose gel containing 
antiserum was prepared just before the end of the first dimensional 
eletrophoresis. Four agarose tablets were dissolved in 18 ml of 
deionized distilled water by heating. The agarose gel was cooled to 
48 C in a water bath while 2 ml of antiserum was warmed to the same 
temperature. .Antiserum was added to the agarpse gel and the mixture 
was used immediately. After first dimensional electrophoreisis, four 
agarose strips, (6 cm x 1.5 cm) containing antigen were cut and 
transferred to a plastic plate side by side so that a 1.5 cm x 24 cm 
agarose·strip was made in a line 3.5 cm from the cathodal end. The 
remaining space on the plate was then covered with 2 mm thick agarose 
containing antisera at the anodal end and with plain agarose at the 
cathodal end. For .CIE with intermediate gel, the antibody containing 
gel was divided into two parts. An intermediate gel containing one 
antiserum covered a width of 1 cm toward the anodal end and next to 
the antigen-containing agarose strip. The remaining space toward the 
anodal end was covered with agarose gel containing another antiserum. 
Electrophoresis in the second dimension was performed for 20 h at 60 
volts. For fused rocket immunoelectrophoresis, a 10 cm x 10 cm glass 
plate was separated into two portions by use of a brass bar placed 5 
cm 'from the cathodal end. The cathodal portion was cast with plain 
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agarose. After gelling, antigen wells were punched out evenly about 5 
mm apart at· alternate positions in two parallel lines across the 
plate. Antigen preparations (10 ul) were added to the wells and the 
plate were incubated for l h at room temperature in a humidified 
chambe~, After incubation, the gel was trimmed so that the anodal end 
of the gel was about 0.5 cm from the wells. The remainder of the 
plate was covered with agarose gel containing antiserum and 
electrophoresis was performed for 20 h at 60 volts. After completion 
of the electrophoresis, the plate was washed in a PBS solution 
containing EDTA (Sigma) for 2 days, dried in an oven at 50 C, stained 
with 0.2% amide black l0B (Corning Medical and Scientific, Palo Alto, 
CA) for 5 min,' washed with 5% acetic acid solution and dried in an 
oVen. 
Sucrose density gradient centrifugation 
Thirteen ml of a sucrose gradient consisting_ of 5 to 40%. iwt/vol) 
sucrose in PBS solution was prepared in_a 20 ml cellulose nitrate tube 
(Beckman Instruments Inc., Palo Alto, CA). Five ml of KSCN extract 
treated with hyaluronidase were applied on top of the gradient and 
centrifuged at 67,000 x .g .for 16 h. After centrifugation, fractions 
were collected from the top to the bottom of the tube. The first 
fraction was collected in a volume of 5 ml and the remainder was 
collected in a series of l ml volumes. Each fraction was analyzed by 
fused rocket immunoelectrophoresis, dialyzed against tris-HCl buffer 
and stored at -20 c. 
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Chemical analysis 
Bacterial fractions were assayed for basic chemical contents • 
. Total carbohydrate was determined by the phenol-sulfuric acid 
procedure (15), using glucose (Sigma) as a standard. Protein content 
was determined colorimentrically from the reaction of protein with 
Serva blue G dye (Serva Fine Chemicals, Inc., Long Island, N. Y.), 
using bovine serum albumin (Sigma) as a standard (30). 2-keto-3-
deoxyoctonate (KOO) content, a component of lipopolysaccharide-
containg materials of Gram-negative bacteria, was determined 
colorimetrically from the reaction of KOO with sulfuric acid, periodic 
acid, sodium arsenite and thiobarbituric acid, using a commercial KDO 
Ri:eparation (Sigma) as a stand.ard (21). 
Results 
Immunogenicity and cross-protectivity of KSCN_ extracts 
To evaluate the immunogenic potential of KSCN extracts of P. 
multocida,. mice were inmunized with KSCN extracts of one non-virulent 
and five virulent P. multocida strains and challenged with the . -- ',' 
virulent strains. Mice immunized with the KSCN extract from virulent 
strains showed signs of depression for several hours after 
immunization but protected.against challenge with the homologous 
strain (Table 2) • Control mice as well as some immunized mice died 
during the period between 12 and 72 h after challenge exposure. Also, 
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Table 2. Immunogenicity in mice of KSCN extracts from several 
strains of P. multocida 
------------------------------------------------------------------
Challenge (No. of survival/No. tested) 
exposure P-2383 P-1062 P-8103889 P-813310 P-92481 
------------------------------------------------------------------
c.f.u. 160 130 230 120 150 
Immunization with 
KSCN Extract of 
P-2383 9/10 9/10 0/10 4/10 10/10 
P-1062 1/10 9/10 0/10 1/10 10/10 
P-8103889 2/10 7/10 7/10 5/10 10/11 
P-813310 1/9 2/10 0/10 9/10 10/10 
P-92481 0/10 4/10 0/10 2/10 10/10 
P-03894 0/10 1/10 0/10 8/10 8/10 
----------------~-------------------------------------------------
Control 0/9 0/9 0/9 3/10 5/10 
. . 
~----------------------------------------------~---~----------~--
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many of the surviving mice were clinically ill up to 72 h after the 
challenge exposure, but gradually recovered. There was no consistent 
reciprocal protection between different strains of a serotype 
indicating no correlation between serotype and cross-protection of 
' mice. For example, mice immunized with the KSCN extract of P-2383 
were protected against the heterologous challenge exposure to P-1062 
and P-92481. However, mice immunized with the.KSCN extracts of P-1062 
and P~92481 were not protected against the challenge with P-2383. 
Selection of rabbit antisera and antigenic analysis of the KSCN 
extract 
'lb analyze the antigenic content of KSCN extracts,.rabbit anti-P. 
multocida sera were prepared. In ge~eral, rabbits immunized with RP 
fraction produced better antisera for use in CIE than those immunized 
with WC fraction or KSCN extract (Fig. lA, lB, lC). Since antisera 
were variable in quality, those sera which showed the most abundant 
and clearest precipitation lines on the CIE plates were ~elected. 
Although the antigenic content of the KSCN extracts was analyzed by 
irnmunoelectrophoretic procedure utilizing different combinations of 
antigens and antisera, two antiserum pools (one for 2383 and one for 
1062) .were prepared by mixing equal volumes of selected homologous. 
antisera. 'lb compare antigenic similarities and differences between 
KSCN extracts of P-2383 and P-1062, antigenic content of the KSCN 
extracts were analyzed by CIE, CIE with intermediate gel and tandan-
CIE us~ng homologous and heterologous antisera.· Because the 
·' 
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c 
Fig. 1. Crossed irrununoelectrophoresis of P-2383 KSCN extact with 
selected rabbit P-2383 antisera. A: KSCN antiserum. B: RP 
antiserum. C: WC antiserum. 
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concentration of antigen and antibody utilized for 
inununoelectrophoresis influenced results, the procedure was 
standardized to 5 ul of antigen and a 1:10 concentration of the 
antisera. Optimal condition as indicated by the greatest number of 
precipitation lines in CIE was determined by varying the antigen 
concentration. Cross-reacting components were determined and numbered 
by the principles of electrophoresis (1) such as distance moved in 
CIE, iine of identity in tandom-CIE, and presence or absence in CIE 
with intermediate gel. This approach demonstrated that at least 25 
different antigenic components could be demonstrated in P-2383 KSCN 
extract with homologous antiserum (Fig. 2A), 23 components from P-2383 
KSCN extract reacted with 1062 antiserum (Fig. 2B), 24 components from 
P~l062 KSCN extract with 1062 antiserum (Fig. 2C) and 21 components 
from P-1062 KSCN extract with 2383 antiserum (Fig. 2D). Most 
antigenic components were found to be corrunon to both.extracts. Some 
components, 8, 10 and 20, were not identified with the pooled 
antiserum pools as illustrated; these components were clearly 
identified with the selected individual antiserum. Two components, 11 
and 12, appeared at the same positions in CIE in similar patterns in 
both extracts when homologous antisera were used, but were not 
detected with heterologous antisera. This indicated that these 
components of the two strains may be similar i[\ their chemical 
structure but have a strain-specific antigenic determinant. It has. 
been suggested that lipopolysaccharide--containing antigens would be 
effective inununogehs against f,!_ multocida infection (4, 16, 31, 32) as 
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Fig. 2. Crossed irranunoelectrophoresis of the KSCN extracts of strain 
P-2383 and P-1062. A: P-2383 KSCN extract with 2383 
antiserum pool. B: P-2383 KSCN extract with 1062 antiserum 
pool. C: P-1062 KSCN extract with 2383 antiserum pool. D: 
P-1062 KSCN extract with 1062 antiserum pool. 
. r' 
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well as for serotyping organisms (Bl. ~ multocida lipopolysaccharide 
was prepared and examined by CIE to verify the existance of a 
corresponding precipitation line (s) in the KSCN extracts. Component 
l; present in both KSCN extracts, was appeared to be the corresponding 
precipitation line with the lipopolysacharide. This component was 
purified for further charaterization. 
Isolation of component l Ex_ the sucrose density gradient 
centrifugation· 
'lb purify component 1, the KSCN extract was centrifuged in a 
sucrose density gradient. Fused-rocket immunoelectrophoretic analysis 
of fractions collected following centrifugation revealed a 
distribution of components from top to bottom of the gradient (Fig. 
3A) • Most of the antigenic components of the P-2383 KSCN extract 
remained in the region of low sucrose concentration (less than 20%). 
' 
A.single component was observed in the bottom half of the gradient as 
indicated .by CIE of pooled fractions 12 to 16 (Fig. 3B). The CIE 
analysis of this component was found to be component 1 of P-2383 KSCN 
extract (Fig. lA). The bottom region of P-1062 KSCN extract in 
sucrose density gradient contained primarily 0ne component with minor 
contamination (Fig. 3C). The isolated component of each KSCN extract 
will be referred to as P-2383-1 and P-1062-1, respectively.· 
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Fig. 3. Irrununoelectrophoresis of fractions by sucrose density 
gradient centrifugation. A: Fused-rocket 
irrununoelectrophopresis of fractions of P-2383 KSCN extract 
and agarose gel contained 2383 antiserum pool. B: CIE of 
component 1 of P-2383 KSCN extract and agarose gel contained 
2383 antiseurn pool. C: CIE of cornEX>nent 1 of P-1062 KSCN 
xtract and agarose gel contained 1062 antiserum pool. 
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Table 3. Inununogenicity of isolated components from the KSCN 
extracts in mice 
~--------------------------------------------------------------------
Challenge (No. survival/ No. tested) 
P-2383 P-1062 P-8103889 
Experiment 
c.f.u. (x 100) 
Inununization with 
P-2383-1 
P-1062-1 
1 2 3 
11 13 1.6 
5/5 10/10 10/10 
1/5 2/5 
1 
10 
5/5 
2/5 
2 3 
11 1.3 
8/10 10/10 
2/5 
3 
2.3 
4/10 
-----------------------------------~------------~-~--------~----
Control 0/5 0/7 0/10 0/5 0/6 0/10 0/10 
------------------------------------------------------~------------~-
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Immunogenicity of the isolated ccinponents 
The immunogenici ty of the isolated canponents in mice was 
examined in three separate experiments. Immunization of mice with P-
2383-1 protected all of the mice against a homologous challenge w·ith 
P-2383 that killed 100% of the control mice (Table 3) • The mice 
immunized with P-2383-1 showed no clinical signs of sickness after 
immunization or challenge while the mice immun~zed with the KSCN 
extract did. Immunization of mice with component 1 also protected 
mice against heterologous challenge with P-1062 (92%) and to some 
extent against P-8103889 (40%). Immunization of mice with P-1062-1 
protected only 40% of the mice against a homologous challenge and only 
30% of the mic,e against a heterologous challenge with P-2383. 
Chemical analysis of the isolated COll!JXlnent 
P-2383-1 contained approximately 12% (wt/wt) carbohydrate and 27% 
(wt/wt) protein while P-1062-1 contained 14% and 12% respectively. 
KDO was not detected in the two isolated components at the level of 5 
mg dry weight per ml of the starting material. 
Discussion 
KSCN extracts of P. multocida have previously been reported to be 
effective immunogens against Pasteurella infection induced by 
homologous and heterologous strains (3, 17, 26, 27, 28). In 
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confirmation of previous findings, the results of mouse protection 
tests indicated that KSCN extracts were immunogenic. However, the 
results also indicated that KSCN extracts did not induce substantial 
cross-protection even between different strains of the same serotype. 
While there may be some correlation within a serotype of ~ multocida 
such as antigenic structure, host susceptibility and strain virulence 
(14), it does not necessarily mean that the serotyping antigens, 
capsular or somatic, are the same as the protective antigen(s). As 
indicated by the antigenic comparison of the two KSCN extracts by CIE 
techniques, most of the antigenic components were common to both 
extracts. The lack of cross-protection between different strains of a 
serotype is probably due to; (1) absence of an important common 
protective antigenic component(s), or (2) variation in some of the 
antigenic determinants associated with the protective antigenic 
component(s). Obviously, although the strains shared many common 
antigenic components, only one or a few of these are assoc.iated with 
protection in mice against the disease. Therefore, identification of 
the protective factor(s) resident in various preparations by antigenic 
i . 
. analysis and chemical charaterization would permit develoµnent of 
immunogens capable of protection against a variety of strains. 
As indicated by.clinical observation of mice followi~g 
immunization and challenge exposure, the isolated component appeared 
to be a better inmunogen than the crude extract. This may be a dose 
effect since the quantity of component 1 could not be related to the 
crude extract. This finding could also be an effect of purity of 
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immunizing preparation. In general, an immunogen containing a small 
number of antigenic components will induce a betj:er immunogenic 
response than a highly complex antigenic mixture. This happening can 
be the result of antigenic competition or the presence of 
immunosuppressive factor(s) in the complex antigenic mixture. All of 
the antigenic components can produce antibodies in animals, however, 
only a few of them may induce protection against the microbial 
infection. It is possible that some of the antigenic components may 
have a detrimental effect on immunologic function rather than a 
protective effect. Evidence found at section I of this thesis· 
indicated that a surface material of P. multocida inhibited 
antibactericidal fuctions of bovine neutrophil. 
P-2383-1. denonstrated irnrnunogenicity as indicated by complete or 
partial resistance of mice to challenge with various stra,ins. Failure 
of complete protection against heterologous strains would indicate 
some variation in the protective antigen of this microorganism. This 
finding might also be explained by the marked virulence of these 
strains for mice. However, this variation was not evident from the 
challenge experiment in which the 1050 of the organisms was 
determined. Chemical analysis of the two components denonstrated that 
P-2383-1. contained.more protein than P-1062-1 and may be the reason P-
2383-1 .is a better immunogen than P-1062-1. This may reflect loss or 
alteration of crucial antigenic determinants of P-1062. This organism 
has been maintained on artificial medium in the laboratory for a long 
period of time and antigenic alteration would be expected. 
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'!he chemical nature of P-2383-1 was similar to the immunogenic 
complex described by .Ganfield et al. (16). Their material was 
purified from a saline extract and was a high-molecular weight 
protein-polysaccharide complex contained 25 to 27% protein and 10.7% 
carbohydrate. Thus, the chemical composition was nearly identical to 
the extract prepared for this experimentation. Further comparison is 
difficult since Ganfield et al. were able to determine the presence of 
lipid but they did not determine presence or absence of KDO. KDO was 
not detected in P-2383-1 which might indicate that the fraction does 
not contain lipopolysaccharide. However, although KDO is a well-known 
component of lipopolysaccharide of Gram-negative organisms (21), it is 
not universally present in all lipopolysaccharide preparations. The 
observation that P-2383-1 is chemically similar to Ganfield's 
preparation and both.are immunogenic would indicate that they are 
probably similar material even though they were isolated by different 
methods from different strains of P. multocida. 
This experimentation demonstrated that KSCN extracts of P. 
multocida were immunogenic but had no consistent re.ciprocal protection 
between different strains of a serotype. The lack of cross-protection 
indicated that the various strains differed qualitatively or 
quantitatively in protective antigenic determinants. Evidence from 
CIE studies of P-2383 and P-1062 KSCN extracts would indicate that 
there are qualitative difference in component 1 that contribute to 
lack of cross-protection. More studies are needed to further 
characterize the protective antigenic component as well· as the· 
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protective antigenic determinant to verify the relationship between 
different strains of P. multocida. 
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GENERAL SUMMARY 
The objective of this research project was to characterize the 
biological activities of fractions of type A Pasteurella multocida (P. 
multocida) • By the use of a strain connnonly utilized for production 
of bacterins (P-1062) and several clinical isolates (especially P-
'2383), the bacterial fractions were prepared. Examination of surface 
materials of type A !:=_multocida exhibited both inhibitory and 
protective properties. 
Phagocytosis (ingestion of bacteria) and protein iodination 
(halogenation of ingested bacteria) by bovine polymorphonuclear 
leukocytes (PMNs) were inhibited in the presence of live cells, heat-
killed whole cells, or saline-extracted capsule but not in the 
presence of the decapsulated heat-ki.lled cells. None of bacterial 
fractions inhibited nitroblue tetrazolium reduction (oxidative 
metabolism) by the PMNs. PMN inhibitory factor was characterized as a 
heat-stable capsular material of greater than 300,000 molecular 
weight. 
Potassium thiocyanate (KSCN) extracts of several .!:=_ multocida 
strains exhibited immunogenicity in mice against challenge with the 
virulent homologous bacterium. However, mice immunized with KSCN 
extracts were not completly protected against heterologous virulent 
strains of the same or similar serotypes indicating no correlation 
between serotypes and cross-protection of mice. Antigenic analysis of 
the KSCN extracts by crossed illlllunoelectrophoresis techniques revealed 
93 
at least 25 different antigenic components. A lipopolysaccharide-like 
component of the KSCN extracts was isolated by sucrose density 
gradient centrifugation. The component isolated from P-2383 extract 
sedimented rapidly indicating a high molecular weight material which 
contained 12% carbohydrate and 27% protein. Immunization of mice with 
this component demonstrated resistance to challenge with the 
homologous strain and some degree of protection against certain 
heterologous strains. 
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